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Abstract 
 
Cognitive impairment and altered drug sensitivity are two commonly reported 
behavioral outcomes of amphetamine abuse.  Individuals who begin using 
amphetamine during adolescence may have an increased risk of developing drug-
related problems because of maturational changes in mesocorticolimbic circuitry that 
are specific to this stage of development.  The studies presented here were designed to 
assess long-term effects of amphetamine on cognition, dopamine receptor function, and 
prefrontal cortex (PFC) activity, with a focus on the consequences of drug exposure 
during adolescence.  Chapter 1 includes a review of the literature on substance abuse 
and PFC dysfunction along with the specific aims of the studies described in the 
following chapters.  Chapter 2 describes studies of drug-induced psychomotor activity 
and measures of working memory in rats exposed to amphetamine during adolescence 
or adulthood.  Results suggest long-term effects of amphetamine on cognition vary 
according to the age of exposure.  The experiments in Chapter 3 investigated the 
protracted effects of repeated amphetamine exposure during adolescence on 
psychomotor behavior and medial PFC function in young adulthood.  Relative to 
controls, rats pre-exposed to amphetamine displayed psychomotor sensitization when 
challenged with amphetamine and heightened responsiveness to D1 and D2 receptor 
agonists.  Expression of sensitization to amphetamine was attenuated in pre-exposed 
rats following challenges with a D1 or D2 receptor antagonist.  The long-term functional 
impact of amphetamine on medial PFC neurons was assessed using single-unit 
recordings in awake behaving rats.  Young adult rats were challenged with 
amphetamine followed by a D1 or D2 receptor antagonist.  The proportion of 
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amphetamine-responsive neurons and the pattern of spike activity was altered in 
animals exposed to amphetamine during adolescence relative to controls.  Finally, 
Chapter 4 includes a general discussion on the results and implications of the 
experiments described in this dissertation.  Taken together, the research presented 
here demonstrates age-dependent effects of amphetamine on cognition and highlights 
the long-lasting impact of amphetamine exposure on dopamine and medial PFC 
function.  
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Chapter 1.  General Introduction 
 
Substance Abuse and Prefrontal Cortex Dysfunction 
According to the United Nations Office on Drugs and Crime, over 200 million 
people worldwide use illicit substances each year (UNODC, 2011).  In the United States 
alone, illicit drug abuse and substance use disorders cost nearly $500 billion annually 
(Koob and le Moal, 2006).  The availability and use of psychoactive substances 
increased dramatically over the 20th century.  In 1971, a growing concern over the 
rampant use of these drugs led President Richard Nixon to declare drug abuse “public 
enemy number one.”  Yet, drug use and abuse continues to be widespread in our 
society despite boundless legislative and judicial efforts over the last 50 years.  In fact, 
Americans, while only representing 4% of the human population, use approximately 
two-thirds of the world’s illicit drugs (Manchikanti, 2007).  Over 90 million people in the 
United States currently have a substance use disorder, which accounts for nearly 50% 
of the total incidence of mental illness in the country (Regier et al., 1988; Kessler et al., 
1994; Madras, 2010).  
While trends in drug use change over time, amphetamine remains one of the 
most commonly used illicit drugs in the world – second only to marijuana (UNODC, 
2011).  In the United States, nearly 20 million people 12 years of age and older report 
using amphetamine in the previous month and nearly 500,000 Americans currently 
suffer from amphetamine dependence (Johnston et al., 2012).  Nonetheless, 
amphetamine remains a schedule II substance with well documented clinical efficacy 
(Advokat, 2010).  Effective for the treatment of attention-deficit hyperactivity disorder 
(ADHD) and narcolepsy, amphetamine is capable of enhancing cognitive performance, 
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mood, arousal, alertness, and motivation (Weitzner, 1965; Holliday et al., 1964; Smith 
and Davis, 1977; Chait et al., 1988; Kelly et al., 1993; Soetens et al., 1993, 1995; 
Gabbay, 2003; Childs and de Wit, 2009, 2011).  However, misuse of this drug can lead 
to a host of physiological and psychological problems (Berman et al., 2009).  
Previous reports indicate that people with a history of amphetamine abuse 
display significant deficits in decision-making and information processing (Rogers et al., 
1999; Ornstein et al., 2000).  Interestingly, these deficits were found to be more severe 
in amphetamine users compared to those who use other drugs of abuse (e.g. opiates, 
Rogers et al., 1999).  Recent clinical findings suggest that cognitive impairment is not 
just an outcome of drug abuse, but may actually contribute to the etiology of substance 
use disorders.  In patients seeking treatment for psychostimulant dependence, the 
severity of cognitive dysfunction is predictive of relapse and dropout during drug 
rehabilitation programs (Aharonovich et al., 2006; Vocci, 2008; Fox et al., 2009).  
Hence, drug users who display the greatest cognitive impairment have the least 
success in taking control over their drug use.  
There is mounting evidence that uncontrollable drug use is due to 
neuroadaptations within the prefrontal cortex (PFC) and corticolimbic circuitry (Goldstein 
and Volkow, 2002; Bolla et al., 2004; Kalivas, 2009; Connolly et al., 2011).  The 
cognitive deficits that emerge following prolonged exposure to psychostimulants overlap 
with those displayed by people with PFC damage (McKetin and Mattick, 1997, 1998; 
Jentsch and Taylor, 1999; Rogers et al., 1999; Ornstein et al., 2000; van Holst and 
Schilt, 2011).  Cognitive functions that are mediated by the PFC are particularly 
sensitive to repeated drug exposure (Jentsch and Taylor, 1999; Rogers and Robbins, 
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2001).  For example, individuals characterized as highly dependent on amphetamine 
are impaired on tests of verbal memory, attention, and delayed recall (McKetin and 
Mattick, 1997, 1998).  Thus, it’s plausible that sub-optimal performance on goal-directed 
tasks involving these cognitive skills may be related to drug-induced plasticity in the 
PFC. 
With extensive connectivity to other regions of the mesocorticolimbic circuit, the 
medial PFC plays a key role in goal-directed behavior (Robbins, 1996; Hauser, 1999).  
The PFC subserves a wide variety of cognitive functions, including so-called “higher-
order” executive functions, as well as conditioned behaviors.  Previous studies indicate 
that damaging the medial PFC, or disrupting connectivity between the medial PFC and 
mesolimbic nodes in this circuitry, can lead to impairments in cognitive performance.  
For example, disconnection of medial PFC input to the nucleus accumbens impedes 
behavioral flexibility in the attentional set-shifting task (Goto and Grace, 2005).  Intact 
medial PFC functioning is also important for instrumental and Pavlovian conditioning 
(Baldwin et al., 2002; Chudasama and Robbins, 2003; Hitchcott et al., 2007; Homayoun 
and Moghaddam, 2009; Naneix et al., 2009; Nelson, et al., 2010; Winter et al., 2009; 
Lex and Hauber, 2010).  Instrumental conditioning is predicated on the ability of an 
animal to learn and remember the contingencies between their own actions and 
outcomes.  In contingency degradation tests, control rats adjust their behavior (i.e., 
decrease lever pressing) when food rewards are no longer contingent on lever pressing 
(i.e., food pellets are delivered randomly).  Rats with medial PFC lesions, in contrast, fail 
to recognize the change in contingency and continue to emit responses at a high rate 
(Corbit and Balleine, 2003; Naniex et al., 2009).  Interestingly, the medial PFC seems to 
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be particularly important during acquisition of contingencies.  Inactivation of this brain 
region after training does not alter the expression of action-outcome associations 
already acquired (Tran-Tu-Yen et al., 2009).  Lesions of the medial PFC also disrupt 
animals’ ability to encode Pavlovian stimuli and adjust their behavior using the 
predictive information relayed by conditioned stimuli.  Lesioned animals show 
indiscriminate Pavlovian conditioned responses, while intact animals learn stimulus 
associations and primarily emit conditioned responses when conditioned stimuli are 
presented (Broersen et al., 1996; Parkinson et al., 2000; Nelson et al., 2010).     
Lesioning the PFC can lead to significant performance deficits on tasks that 
require animals to allocate attention to and remember various features of reward-related 
stimuli.  Damage to the medial PFC impairs response accuracy in working memory 
tasks, including the 5-choice serial reaction time task (Muir et al., 1996), attentional set-
shifting (Birrell and Brown, 2000; McGaughy et al., 2008), delayed alternation (Izaki et 
al., 2008), and operant delayed matching-to-position (DMTP) tasks (Sloan et al., 2006).  
The medial PFC plays a relatively selective and dissociable role in cognition, and 
damage does not always lead to measurable changes in cognitive performance.  For 
example, inactivation of the medial PFC does not seem to influence spatial learning in 
the Morris water maze (Sloan et al., 2006).  However, there are many behavioral assays 
that may be used to probe medial PFC function.  Among them, the DMTP task is well 
suited to assess distinct changes in working memory and mnemonic processes 
(Dunnett, 1985).  Optimal performance on DMTP requires animals to remember the 
location of a sample stimulus (e.g., lever) over short delay intervals that change across 
trials.  Because this task includes discrete stimulus events and trials, the contribution of 
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attention and memory processes to performance can be dissociated.  For example, 
changes in attentional control can be measured by analyzing responsiveness to the 
sample stimulus and to changes in choice accuracy that are independent of delay.  
Working memory function may be assessed by measuring choice accuracy across the 
different delay intervals.  
The effects of psychostimulants on executive function and conditioned behavior 
have been well documented in both humans (Weitzner et al., 1965; Hurst et al., 1969) 
and laboratory animals (Stein, 1964; Clark and Steele, 1966).  Amphetamine, in 
particular, produces marked effects on attention, decision-making, working memory, 
conditioned behavior, and reward-related learning (Clark and Steele, 1966; Wyvell and 
Berridge, 2001; O’Tuathaigh et al., 2004; Tindell et al., 2005; Horsley et al., 2008; 
Gerdjikov et al., 2011).  While some studies report cognitive improvement with 
amphetamine (Hitchcott et al., 1997; Harmer and Phillips, 1998; 1999; Simon and 
Setlow, 2006; Mendez et al, 2009), others argue that these changes in cognition may be 
pathological in nature and ultimately contribute to maladaptive goal-directed behavior 
(Taylor and Robbins, 1984; Taylor and Horger, 1999; Wyvell and Berridge, 2001; Everitt 
and Wolf, 2002; Kantini et al., 2004; Simon et al., 2009).  For example, repeated 
administration of 2 mg/kg amphetamine for five days enhances rats’ acquisition of an 
appetitive associative learning task (Harmer and Phillips, 1998); however, similar 
treatment regimens have the potential to impair goal-directed behavior by disrupting 
cognitive executive functioning.  
Amphetamine has a significant impact on cognitive processes mediated by the 
PFC.  However, the majority of studies have focused on the short-term effects of 
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amphetamine, while the long-term cognitive consequences of repeated amphetamine 
exposure are not well characterized, particularly in populations with heightened 
sensitivity to psychostimulant-induced plasticity (e.g., adolescents). 
 
Summary & Rationale  
Each year, more people abuse amphetamine than heroin and cocaine combined 
(UNODC, 2011).  What’s more, cognitive functioning in those who abuse amphetamine 
is often so disordered that their performance on cognitive assessments cannot be 
distinguished from people with frontal lobe damage or schizophrenia (Rogers et al., 
1999; Miller and Cohen, 2001; DSM-IV-TR, 2000).  Findings from clinical studies 
indicate that people who chronically abuse amphetamine often display significant 
impairments in attention, inhibitory control, working memory, information processing, 
and decision-making (McKetin and Mattick, 1997; 1998; Ornstein et al., 2000; Ersche et 
al., 2006).  There is growing evidence that neuroadaptations in the medial PFC and 
mesocorticolimbic network underlie these deficits (Goldstein and Volkow, 2002; Jentsch 
and Taylor, 1999; Kalivas and Volkow, 2005).  During adolescence, there are unique 
structural and functional changes in mesocorticolimbic circuitry occurring, which may 
increase vulnerability to amphetamine-induced dysfunction.  Currently, there is a 
significant gap in our understanding of how repeated drug exposure during maturation 
impacts cognition and medial PFC function long-term.   
In a collaborative effort, our lab and others have sought to address this 
knowledge gap.  Drawing from a wide variety of behavioral neuroscience techniques, 
our research over recent years has revealed unique and long-lasting effects of 
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amphetamine on the brain and behavior as animals transition from adolescence to 
adulthood.   My central hypothesis is that mesocorticolimbic circuitry during 
adolescence is particularly vulnerable to drug-induced plasticity, and repeated exposure 
to amphetamine during adolescence produces lasting effects on medial PFC neural 
activity and behavior. I will test this central hypothesis with the following specific aims: 
 
Aim 1.  To determine the long-term effects of repeated amphetamine exposure, during 
adolescence or adulthood, on performance in a medial PFC-sensitive working memory 
task. 
The frontal cortex continues to develop through the adolescent time period 
(Casey et al., 2005; 2008).  As animals mature from adolescence to adulthood, the PFC 
undergoes significant changes in cell number and morphology (Markham et al., 2007; 
Cunningham et al., 2002).  Glutamate and dopamine systems also continue to mature 
during this stage of development (Crews et al., 2007; Andersen et al., 2000).  Together, 
these ongoing changes in the brain are thought to leave adolescents particularly 
vulnerable to drug-induced plasticity (Andersen et al., 2002; Smith, 2003).  Dopamine 
modulates medial PFC output and is thought to mediate PFC participation in attentional 
control and mnemonic processing via D1 and D2 receptor signaling (Seamans et al., 
2001).  Thus, long-lasting plasticity in dopamine signaling may explain the increased 
vulnerability that adolescent-exposed animals show to protracted drug-induced 
behavior.    
Altered cognitive function in adolescent-exposed animals is associated with 
neuroadaptations in mesocorticolimbic circuitry that may be particular to this age group 
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(Bergstrom et al., 2008).  For example, repeated exposure to nicotine during 
adolescence leads to long-lasting deficits in attention and impulse control that are 
related to altered glutamate and dopamine activity in the medial PFC (Counotte et al., 
2009; 2011).  While the majority of studies do not assess if behavioral and 
neurobiological adaptations are unique to adolescence, Counette and colleagues 
included an adult comparison group and found that drug-induced plasticity was not 
evident in adult-exposed rats.  In a recent study, heightened plasticity in mesocortical 
circuity in adolescent mice was shown to be regulated by dopamine and glutamate 
transmission, and interestingly inhibition of dopamine D2 receptors reversed the long-
lasting neuroadaptations in adulthood (Mastwal et al., 2014). 
Aim 1 of this dissertation addresses this gap in our knowledge by assessing 
cognitive performance in rats repeatedly exposed to amphetamine following a 
protracted drug-free period.  Persistent changes in cognition were characterized using 
an operant-based DMTP task, which has been shown to be sensitive to disruptions of 
medial PFC function.  The experiments described in Chapter 2, investigated the effects 
of repeated amphetamine exposure on working memory performance and attention 
using DMTP.     
 
Aim 2.  To determine if long-lasting neuroadaptations in dopamine receptor function and 
medial PFC activity are present in adult rats exposed to amphetamine during 
adolescence. 
In a recent study, we found that repeated exposure to amphetamine during 
adolescence, but not adulthood, impaired rats’ performance on a medial PFC-sensitive 
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working memory task (Sherrill et al., 2013).  Notably, the cognitive disruptive effects of 
amphetamine were specific to animals exposed during adolescence, a time during 
which dopamine receptors are in flux and the PFC undergoes significant reconfiguration 
(Spear, 2000).  The relationship between mesocorticolimbic dopamine activity and 
working memory function has been well documented (Murphy et al., 1996; Romanides 
et al., 1999; Miller and Cohen, 2001).  Altered dopamine signaling is a central feature of 
psychostimulant sensitization (Pierce and Kalivas, 1997; Steketee, 2003) and may 
underlie the long-lasting effects of amphetamine on cognition and psychomotor 
behavior in adolescent-exposed animals (Teicher et al., 1995; Bolanos et al., 1998). 
The experiments outlined in Chapter 3 were designed to investigate long-lasting effects 
of adolescent amphetamine exposure on psychomotor activity and dopamine receptor 
function.  In addition, the long-term functional impact of amphetamine on medial PFC 
neurons was assessed using single-unit recordings in awake behaving rats. 
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Chapter 2.  Age-dependent effects of repeated amphetamine exposure on working 
memory in rats.1 
 
 
 
 
Abstract 
 
Cognitive dysfunction is a hallmark of chronic psychostimulant misuse.  
Adolescents may have heightened risk of developing drug-induced deficits because 
their brains are already undergoing widespread changes in anatomy and function as a 
normal part of development.  To address this hypothesis, we performed two sets of 
experiments where adolescent and young adult rats were pre-exposed to saline or 
amphetamine (1 or 3 mg/kg) and subsequently tested in a prefrontal cortex (PFC)-
sensitive working memory task.  A total of ten injections of amphetamine or saline (in 
control rats) were given every other day over the course of 19 days.  After rats reached 
adulthood (> 90 days old), cognitive performance was assessed using operant-based 
delayed matching-to-position (DMTP) and delayed nonmatching-to-position (DNMTP) 
tasks.  DNMTP was also assessed following challenges with amphetamine (0.1-1.25 
mg/kg), and ketamine (5.0-10 mg/kg).  In experiment one, we also measured the 
locomotor response following the first and tenth pre-exposure to amphetamine and after 
an amphetamine challenge given at the conclusion of operant testing.  Compared to 
adult-exposed groups, adolescents were less sensitive to the psychomotor effects of 
amphetamine.  However, they were more vulnerable to exposure-induced cognitive  
 
1 
This work was previously published and is reproduced here with permission from the copyright holders.  
Bibliographic information: Sherrill LK, Stanis JJ, Gulley JM (2013) Age-dependent effects of repeated 
amphetamine exposure on working memory in rats. Behav Brain Res 242:84–94. 
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impairments.  For example, adolescent-exposed rats displayed delay-dependent deficits 
in accuracy, increased sensitivity to proactive interference, and required more training to 
reach criterion.  Drug challenges produced deficits in DNMTP performance, but these 
were not dependent on pre-exposure group.  These studies demonstrate age of 
exposure-dependent effects of amphetamine on cognition in a PFC-sensitive task, 
suggesting a heightened sensitivity of adolescents to amphetamine-induced 
neuroplasticity.   
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Introduction 
Amphetamines are among the most commonly used and abused psychoactive 
drugs, with more people taking them each year than heroin and cocaine combined 
(UNODC, 2011).  In the United States alone, nearly 20 million people 12 years of age 
and older are currently using amphetamine and nearly 500,000 Americans meet criteria 
for dependence (SAMHSA, 2011).  Clinical studies indicate a history of AMPH abuse is 
associated with significant deficits in attention, decision-making and information 
processing (Ersche, Clark, London, Robbins, & Sahakian, 2006; McKetin & Mattick, 
1997; McKetin & Mattick, 1998; Ornstein et al., 2000; Rogers et al., 1999; van Holst & 
Schilt, 2011).  In fact, cognitive functioning of chronic abusers is often so disordered that 
their performance during assessments is difficult to distinguish from that of patients with 
frontal lobe damage (Miller & Cohen, 2001; Rogers et al., 1999). 
Corticolimbic brain circuits, including the interconnected prefrontal cortex (PFC), 
dorsal striatum, nucleus accumbens, and hippocampus, are critically important for 
normal cognitive functioning (Arnsten & Rubia, 2012; Miller & Cohen, 2001) and 
accumulating evidence suggests that drug-induced plasticity in these regions plays an 
important role in psychostimulant-induced cognitive dysfunction (Goldstein & Volkow, 
2002; Jentsch & Taylor, 1999; Kalivas & Volkow, 2005; Vanderschuren & Kalivas, 
2000).  For example, neuroimaging studies in recovering addicts have revealed that the 
deficits they exhibit in decision-making and memory are associated with functional 
abnormalities in the striatum and frontal cortex (Bolla et al., 2003; Volkow et al., 2001).  
Studies in adult laboratory animals suggest that repeated exposure to amphetamine 
leads to enduring deficits in attention and working memory that are associated with 
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reductions and elevations in dopamine and glutamate signaling, respectively, in the 
PFC (Fletcher, Tenn, Rizos, Lovic, & Kapur, 2005; Fletcher, Tenn, Sinyard, Rizos, & 
Kapur, 2007; Hedou, Feldon, & Heidbreder, 1999; Hedou, Homberg, Feldon, & 
Heidbreder, 2001; Lu & Wolf, 1999; Peterson, Wolf, & White, 2000). 
One factor that might contribute to amphetamine’s potential to induce cognitive 
dysfunction is the age at which exposure occurs.  Like most other drugs of abuse, 
amphetamine use typically starts during adolescence (DeWit, Offord, & Wong, 1997; 
Johnston, O'Malley, Bachman, & Schulenberg, 2012), which is the transitional period 
between childhood and adulthood that begins at approximately 12 years of age and 
extends to the early or mid-twenties (Dahl, 2004; Lenroot & Giedd, 2006).  Notably, the 
frontal cortex continues to develop throughout the adolescent time period (Casey, 
Galvan, & Hare, 2005; Casey, Getz, & Galvan, 2008), with alterations in cell number 
and morphology (Cunningham, Bhattacharyya, & Benes, 2002; Markham, Morris, & 
Juraska, 2007) and increased synaptic pruning (Huttenlocher & Dabholkar, 1997) 
among the most prominent changes that occur.  Glutamate and dopamine systems also 
continue to mature during this stage of development (Andersen, Thompson, Rutstein, 
Hostetter, & Teicher, 2000; Crews, He, & Hodge, 2007; Kalsbeek, Voorn, Buijs, Pool, & 
Uylings, 1988; Moll et al., 2000).  For example, dopamine D1 and D2 receptor 
expression in the rodent PFC, nucleus accumbens and dorsal striatum increases 
significantly during early adolescence and subsequently declines by as much as 60% as 
animals reach young adulthood (Andersen et al., 2000; Brenhouse, Sonntag, & 
Andersen, 2008).  Thus, the adolescent brain may be particularly susceptible to drug-
induced neuroadaptations and associated cognitive changes because of the unique 
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effects of drugs in the developing brain (Andersen, Arvanitogiannis, Pliakas, LeBlanc, & 
Carlezon, 2002; Smith, 2003).   
Evidence for enhanced vulnerability to drug-induced plasticity in adolescents has 
come primarily from studies in rats, where adolescence has been conservatively defined 
as beginning around postnatal day (P) 28 and extending to P42 (Spear, 2000) or 
perhaps as late as P60 (Brenhouse & Andersen, 2011; Tirelli, Laviola, & Adriani, 2003).  
For example, studies of adults exposed to amphetamine, cocaine, methylphenidate, or 
nicotine during adolescence have reported enduring deficits in cognitive tasks that 
assess attention, memory, decision making, and impulse control (Adriani et al., 2006; 
Bethancourt, Camarena, & Britton, 2009; Counotte et al., 2009; Hankosky & Gulley, 
2012; Harvey, Dembro, Rajagopalan, Mutebi, & Kantak, 2009; Richetto, Feldon, Riva, & 
Meyer, 2012; Santucci & Rabidou, 2011; Vorhees et al., 2005).  Some of these 
cognitive dysfunctions have been associated with alterations in multiple measures of 
neural function and gene expression in the PFC, dorsal striatum and nucleus 
accumbens (Adriani et al., 2006; Adriani, Canese, Podo, & Laviola, 2007; Black et al., 
2006; Counotte et al., 2009; Counotte et al., 2011; Harvey et al., 2009; Labonte et al., 
2011).  In the majority of these studies, however, it is difficult to ascertain if adolescents 
are relatively more sensitive to these effects of drug exposure because comparison 
groups of adult-exposed subjects were rarely utilized.   
The primary aim of the current study was to investigate long-lasting effects of 
repeated amphetamine exposure on locomotor sensitization and cognition in groups of 
subjects exposed during adolescence or adulthood.  In Experiment 1, locomotor activity 
was measured in an open-field arena after the first and last exposure injection and 
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following cognitive testing.  Working memory was assessed using an operant-based 
delayed matching-to-position (DMTP) task that is sensitive to disruptions in medial PFC 
function (Chudasama & Muir, 1997; Sloan, Good, & Dunnett, 2006).  After rats learned 
the task, we also assessed reversal learning by switching to a delayed nonmatching-to-
position (DNMTP) task and then subsequently evaluated the effects of pharmacological 
challenges on task performance using amphetamine and the NMDA antagonist 
ketamine.  In Experiment 2, procedural modifications were made to minimize 
differences in injection and rearing experiences across groups and to increase the 
difficulty of the working memory component of the task.   
  
Materials and Methods 
Subjects.   The male subjects used in these experiments were offspring of male 
and female Sprague-Dawley rats that were originally obtained from Harlan 
(Indianapolis, IN, USA) and were bred in our animal facility.  The exception to this was 
the adult-exposed groups used in Experiment 1; these rats were obtained from Harlan, 
shipped to our facility when they were postnatal day (P) 75, and housed individually 
upon their arrival.  Rats born in our facility were housed 2-3 per cage following weaning 
at P24 and were housed individually after P85.  All rats were maintained on a 12:12 hr 
light/dark cycle (lights on at 0800) with experimental sessions conducted between 0900 
and 1800 hr.  Rats were handled at least three times for ≥ 15 min each prior to being 
used in experiments.  Food was available ad libitum before rats were housed 
individually, but was restricted during operant training and testing so that rats’ weights 
were maintained at approximately 85% of their free feeding weight.  Water was always 
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available ad libitum.  Experimental procedures were approved by the Institutional 
Animal Care and Use Committee at the University of Illinois, Urbana-Champaign, and 
were consistent with the Principles of Laboratory Animal Care (NIH Publication no. 85-
23). 
Apparatus.  Locomotor activity was monitored in open-field arenas (41 x 41 x 41 
cm) consisting of transparent acrylic walls and surrounded by photobeam frames 
(Coulbourn Instruments; Allentown, PA, USA) that recorded horizontal (lower frame; 2.5 
cm above the arena floor) and vertical activity (15 cm above the arena floor).  Computer 
software (TruScan v 2.01, Coulbourn Instruments) was used to record photobeam 
breaks and to calculate distance traveled (m).  Each open-field arena was housed in a 
sound-attenuating cubicle (76 x 80 x 63 cm) that contained a 76 mm speaker fixed to 
one side wall that played white noise (70 dB), two ceiling mounted white lights (4 W 
each), and a centrally mounted overhead camera that captured video for offline analysis 
of stereotyped behavior.  
Operant behavior was assessed in standard operant chambers (Coulbourn 
Instruments). The front panel of each chamber contained a centrally located food trough 
flanked on either side by a retractable lever (i.e., levers A and B).  White cue lights were 
mounted above each lever. The rear wall contained a white houselight located near the 
top of the chamber and a recessed nosepoke port containing a red LED light was 
located near the floor.  Infrared photobeam detectors that were positioned in the food 
trough and nosepoke port were used to monitor head entries.  Graphic State (v3.1; 
Coulbourn Instruments) was used for automated chamber control and data collection. 
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Drugs.  D-amphetamine sulfate (Experiments 1 and 2) was purchased from 
Sigma-Aldrich (St. Louis, MO, USA) and dissolved in sterile saline (0.9% NaCl).  
Ketamine HCl (Experiment 1) was obtained in a 100 mg/ml injectable solution (Ketaset; 
Pfizer Animal Health; Fort Dodge, IA, USA) and diluted with sterile saline to the 
appropriate concentrations for injection.  All dosages were calculated based on the 
weight of the salt and injections were given at a volume of 1 ml/kg.    
 
Experiment 1 
 
Pre-treatment.  The male rats used in this experiment (n = 50) were previously 
used in a study of cocaine-induced locomotor activity and were therefore exposed to a 
single injection of 10 mg/kg cocaine at either P35 or P95.  Subsequently, they were 
randomly assigned to one of four groups that received 0.9% saline or 3 mg/kg AMPH 
during late adolescence or young adulthood.  Injections were given using an intermittent 
pattern of exposure with one injection (i.p.) occurring every other day for a total of 10 
injections.  We previously used this procedure to induce long-lasting behavioral 
sensitization (> 3 months) in rats exposed in adulthood (Stanis, Marquez Avila, White, & 
Gulley, 2008).  Rats in the adolescent-exposed groups (n = 9 given saline; n = 15 given 
AMPH) received injections between P37 and P55, whereas those in the adult-exposed 
group (n = 7 given saline; n = 19 given AMPH) were injected between P98 and P116.  
For the first and tenth injections, activity was monitored in the open-field arena 30 min 
before and 60 min after injection.  For injections 2-9, rats were injected in a separate 
test room and were then placed for 60 min in an acrylic tub (46 x 25 x 22 cm) lined with 
hardwood bedding.    
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Working memory task.  When rats were P85 (adolescent exposed) or P120 (adult 
exposed), they were placed on food restriction (~15 g/day) and were trained starting 5 
days later to respond on one of two levers on a continuous reinforcement schedule.  
Using procedures adapted from Dunnett (1985), rats were then trained in daily sessions 
to perform a no-delay version of a matching-to-position task.  For these sessions, which 
consisted of 100 trials, an individual trial began with the illumination of the houselight 
and a 5-s ITI.  Lever A or B was then presented randomly (with equal probability) and 
rats were required to respond on the extended lever within 10 s (i.e., sample phase).  
These responses were followed by retraction of this sample lever and illumination of the 
cue light in the trough.  After the rat poked its nose into the trough, the sample lever was 
presented again (i.e., choice phase) and a food pellet was subsequently delivered after 
the rat made another response on that lever.  If no response was made, the lever was 
retracted, the houselight was extinguished, and the trial was scored as an omission.  
After at least two of these training sessions, the procedure was repeated except that 
both levers were presented during the choice phase.  At this training stage, responses 
on the sample lever were reinforced with food pellet delivery, whereas those that were 
made on the non-sample lever were scored as incorrect and a 5-s ITI was initiated.  
Daily training sessions of 112 trials continued until rats achieved ≥ 85% correct 
performance on two consecutive sessions. 
During the next training stage, trials were modified such that a delay phase was 
introduced between the sample and choice phases.  Delay intervals were randomly 
selected from one of seven durations, with initial training utilizing “short delays” of 0, 1, 
2, 3, 4, 5, and 6 s.  After rats met the performance criterion (≥ 85% correct choices over 
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two consecutive sessions), “moderate” delays of 0, 1, 2, 4, 8, 12, and 16 s were 
introduced.  Following initial training, DMTP “long” delays of 0, 2, 4, 8, 12, 18, and 24 s 
were introduced.  This training progression was chosen to avoid response extinction, 
which sometimes occurs if longer delays are introduced before task acquisition has 
progressed sufficiently.  During these training sessions, each delay was presented on 
16 trials, for a total of 112 trials/session.  After rats reached criterion at the long delays 
on DMTP, they were given five additional training sessions (“overtraining”) before the 
task rule was reversed.  In these delayed nonmatching-to-position (DNMTP) sessions, 
which utilized the long delays (0-24 s), responses during the choice phase that were 
made on the non-sample lever were reinforced.      
 Drug challenges.  Following the last DNMTP training session (i.e., second 
consecutive session of ≥ 85% correct), the effects of challenge injections with AMPH 
and ketamine were assessed in two testing blocks.  For the first block, rats were given 
injections of vehicle (saline; 1 ml/kg, i.p.) or amphetamine (0.3, 0.75, and 1.25 mg/kg, 
i.p.) 5 min before they were placed in the operant chamber for a DNMTP test session.  
Injections were given over five consecutive sessions (i.e., SDDDS, where S = saline 
and D = drug).  The order of drug doses was chosen based on a Latin square design, 
with a particular order assigned to each rat randomly.  Rats were given a day off from 
testing before starting the second block of injections.  For these tests, saline vehicle or 
ketamine (5, 7.5, 10 mg/kg, i.p.) was given 10 min before rats were placed in the 
chamber for their test session.  Injection order was assigned randomly and given over 
five sessions (SDDDS).  After their final operant session, rats were given access to food 
ad libitum.  One week later, all rats were challenged with 3 mg/kg amphetamine (i.p.) 
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using the same open-field locomotor test procedures that were used during their first 
and tenth pre-treatment injections.   
 Data analysis.  Data from rats pre-treated with saline during late adolescence (n 
= 9) or adulthood (n = 7) were combined because there were no statistically significant 
differences between these groups in measures of open-field behavior and working 
memory task performance.  Locomotor activity (ambulation) was quantified as the total 
horizontal distance (m) during the first 60 min post-injection.  This measure was 
calculated from consecutive photobeam breaks (i.e., coordinate changes) using 
computer software (TruScan; Coulbourn Instruments) that subtracted repetitive 
behaviors occurring in the absence of ambulation.  To characterize bouts of repetitive 
movement (i.e., stereotypy), video recordings of open-field test sessions were scored 
using a semi-quantitative method we used previously (Stanis et al., 2008).  Trained 
observers that were not given information about a rat’s group membership scored 30 s 
segments of video taken every 5 min of the 60-min post-injection period.  For each 
segment, behavior was rated for intensity (1-mild, 2-intense, or 3-intense) and duration 
(seconds spent exhibiting the scored behavior; 0-30 s); these values were then 
multiplied to give a single score that could range from 0-90.  These data were analyzed 
using a two-way ANOVA, with treatment day as within-subjects factors and group as 
between-subjects factors.  All main effects and interactions were further analyzed using 
one-way ANOVA and Student-Newman-Keuls comparison procedures.  
 Performance on the working memory task was measured by calculating the 
mean percentage of correct choices across sessions and delay blocks and the number 
of sessions to reach criterion.  In order to assess delay-dependent changes in 
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performance during training, rats mean accuracy across delay blocks was compared on 
the first two sessions a rat from any group met the performance criterion during DMTP 
(sessions 1 and 2) and DNMTP (sessions 6 and 7). Separate two-way repeated 
measures ANOVAs (exposure group x delay) were used to assess delay-dependent 
changes in performance.  A two-way repeated measures ANOVA with treatment group 
as the between-subjects factor and training phase (DMTP and DNMTP) as the within-
subjects factor was used to analyze the number of sessions to reach criteria.  To assess 
the effects of proactive interference on performance, accuracy was compared across 
delays on trials in which the choice response made on the previous trial differed from 
the correct response required on the current trial (i.e. different trials) and on trials where 
the correct choice and previous choice response were congruent (i.e. same trials).  
These data were analyzed separately for DMTP and DNMTP using three-way repeated 
measures ANOVAs (exposure group x delay x trial type).  
Performance following amphetamine and ketamine drug challenges was 
assessed by calculating three measures: mean percent correct, latency to choice, and 
the number of trials omitted during each test session.  These measures were analyzed 
using separate two-way repeated measures ANOVAs with exposure group as the 
between-subjects factor and dose as the within-subjects factor.  Proactive interference 
during drug challenges was assessed using separate three-way ANOVAs (exposure 
group x trial type x dose) for amphetamine and ketamine.  Sessions during which an 
animal failed to complete > 75% of trials were not included in the analysis of percent 
correct. All main effects and interactions were further analyzed using one-way ANOVA 
and Student-Newman-Keuls comparison procedures.  
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Experiment 2 
Pre-treatment.  The experimentally naïve, male rats (n = 46) used in this 
experiment were administered saline or amphetamine using similar methods as those 
used in Experiment 1, but with several changes to the experimental design.  First, all 
rats were offspring of breeders maintained in our facility and they were assigned to 
exposure groups so that rats from each litter were represented within each group.  
Second, rats were given injections (i.p.) every other day during both adolescence (P27-
45) and young adulthood (P85-103).  Those assigned to the control group were given 
saline (1 ml/kg) at both time points, those in the adolescent-exposed groups were given 
amphetamine (1 or 3 mg/kg) during adolescence and saline during adulthood, and 
those in the adult-exposed groups were given saline during adolescence and 
amphetamine (1 or 3 mg/kg) during adulthood.  Following each injection, rats were 
placed individually into the same type of enclosures that were used during injections 2-9 
in Experiment 1, where they remained undisturbed for 60 min post-injection. 
Working memory task.  Rats began operant training after reaching P120.  The 
animals were food deprived (~85%) over a period of 5 days then began lever press 
training on a continuous reinforcement schedule.  Training on the working memory task 
was similar to that described in Experiment 1, with the following changes.  During each 
trial, a cue light was illuminated above the corresponding sample lever and three lever 
presses (FR 3) were required during the sample phase to initiate the delay interval.  In 
addition, during the delay interval, rats were required to nosepoke into the nosepoke 
port located on the rear wall of the chamber.  These modifications were implemented to 
increase the salience of the sample and to discourage further the development of non-
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mnemonic (e.g., positional) strategies (Paule et al., 1998).  A final procedural difference 
from Experiment 1 involved the introduction of longer delay intervals.  Rats were trained 
on DMTP until delay blocks ranged from 0-30 s [delay blocks: 0, 2, 4, 8, 12, 18, 24, 30 
s].  Rats progressed to DNMTP (0-30 s delays) once they achieved ≥ 85% correct on 
two consecutive sessions. 
Data analysis.  Performance during training on DMTP and DNTMP was 
assessed as described for Experiment 1, with individual rats’ mean performance across 
sessions 1 and 2 (DMTP) and 4 and 5 (DNMTP) used in the analysis.  Separate two-
way ANOVAs for DMTP and DNMTP were conducted to investigate within session 
delay-dependent changes in accuracy.  A two-way repeated measures ANOVA was 
used to analyze the number of sessions to criterion during DMTP and DNMTP training.  
Proactive interference during DMTP and DNMTP training was assessed using two- and 
three-way repeated measures ANOVAs.  Sessions during which an animal failed to 
complete > 75% of trials were not included in the analysis of percent correct.  All main 
effects and interactions were further analyzed using one-way ANOVA and Student-
Newman-Keuls comparison procedures.  All data are presented as group mean ± SEM. 
 
Results 
Experiment 1 
Amphetamine produced significant changes in ambulation and stereotyped 
behavior following the first (T1) and tenth (T10) injections (Fig. 2.1).  These changes in 
activity were also evident when an amphetamine challenge was given at the conclusion 
of operant testing, which occurred approximately 4 months after pre-treatment for rats in 
the adolescent-exposure group and approximately 3 months for those in the adult-
37 
 
exposed group.  Separate two-way ANOVAs revealed significant interactions between 
group and treatment day for ambulation [F(4,92) = 54.7, p < 0.001] and stereotypy 
[F(4,92) = 14.1, p < 0.001].  Compared to saline-treated controls, rats in both the 
adolescent- and adult-exposed groups exhibited significant increases in ambulation and 
stereotypy after their first injection with 3 mg/kg amphetamine.  For adolescent-exposed 
rats, ambulation was elevated to a similar magnitude following the tenth injection.  In 
adult-exposed rats, however, there was a significant reduction in ambulation following 
injection 10 compared to injection 1.  Both pre-exposed groups showed an increase in 
stereotypy at injection 10 and amphetamine challenge compared to controls.  In 
addition, stereotypy in both pre-exposed groups reached a maximal level following the 
amphetamine challenge injection.  Yet, the overall magnitude of the stereotypy 
response was lower in adolescent-exposed rats compared to the adult-exposed group 
after the tenth and challenge injections.  Thus, sensitization to amphetamine-induced 
stereotypy was still evident in both pre-exposure groups at the time of amphetamine 
challenge, and these high levels of stereotypy were associated with a concomitant 
decrease in ambulatory activity these rats. 
Although the changes in amphetamine-induced activity were greatest in rats 
exposed to the drug during adulthood, significant impairments in performance during the 
working memory task were more robust in adolescent-exposed rats (Fig. 2.2).  Two-way 
repeated measures ANOVA (group x delay) of DMTP accuracy revealed significant 
main effects of exposure group [F(2,47) = 5.30, p < 0.01] and delay [F(6,282) = 172, p < 
0.001], and a significant group x delay interaction [F(12,282) = 1.88, p < 0.05].  Post-hoc 
analysis indicated that the accuracy of adolescent-exposed rats was significantly 
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impaired relative to controls and the adult-exposed group when the delay interval 
exceeded 12 s (Fig. 2.2A).  With repeated training, all rats reached the performance 
criterion.  However, those exposed to amphetamine during adolescence required more 
sessions than rats in the other groups (Fig. 2.2C).  When the task was then reversed to 
DNMTP, performance decreased in all groups and there were no apparent delay-
dependent differences (Fig. 2.2B).  Adolescent exposed rats did require more trials to 
reach the performance criterion, however (Fig. 2.2C).  Two-way repeated measures 
ANOVA of the sessions to criterion data revealed significant main effects of group 
[F(2,47) = 4.20, p < 0.05] and training phase [F(1,47) = 177, p < 0.001].  The interaction 
between group and training phase was not significant (p > 0.05).  
In order to assess the extent to which proactive interference contributed to group 
differences in DMTP performance, accuracy was analyzed on a trial-by-trial basis (Fig. 
2.3).  Analysis of these data indicated that rats were less accurate on ‘different’ trials 
compared to ‘same’ trials when the delay interval exceeded 8 s [significant trial type x 
delay interaction: F(6,282) = 5.90, p < 0.001].  Furthermore, on different trials, 
adolescent-exposed rats were significantly less accurate than control and adult-exposed 
groups at delay intervals 12 s and longer [significant group x delay interaction: 
F(12,282) = 2.53, p < 0.01].  During DNMTP training (data not shown), rats were also 
less accurate on different compared to same trials [main effect of trial type: F(1,46) = 
35.3, p < 0.001], but there were no group differences in susceptibility to proactive 
interference.  
After rats met the performance criterion on DNMTP, they were tested for their 
response to pre-session challenge injections of amphetamine or ketamine (Fig. 2.4).  
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Separate two-way repeated measures ANOVAs (exposure group x dose) for 
amphetamine and ketamine revealed a main effect of dose for AMPH [F(3,6) = 51.9, p < 
0.001].  Accuracy was significantly impaired following each challenge dose of AMPH.  
However, there were no significant effects of ketamine on accuracy [NS main effect of 
dose, p > 0.05], and neither drug was found to influence any one particular group more 
than others [NS main effects of group, ps > 0.05].  Separate three-way repeated 
measures ANOVAs were used to analyze proactive interference during sessions 
following drug challenges (Fig. 2.5).  Amphetamine reduced accuracy on both same and 
different trials, while ketamine impaired performance only on different trials [significant 
trial type x dose interactions: Fs(3,6) = 21.8, ps < 0.001].  Changes in accuracy 
following amphetamine and ketamine were accompanied by significant increases in the 
mean number of trials omitted and choice latency (Table 2.1).  Following challenge with 
0.75 and 1.25 mg/kg amphetamine, and all test doses of ketamine, rats showed a 
significant increase in omissions [main effects of dose: Fs(3,6) = 28.6 and 18.0, 
respectively, ps < 0.001].  There were no significant effects of amphetamine on choice 
latency; however, ketamine increased choice latency at all doses tested relative to 
saline [main effect of dose: F(3,6) = 11.7, p < 0.001]. 
 
Experiment 2 
 
In order to extend the findings from Experiment 1, we modified the pre-treatment 
and working memory task protocols to include a second amphetamine dose, control 
procedures for injection experience, and additional task demands for DMTP and 
DNMTP.  As shown in Figure 2.6, accuracy during DMTP decreased as a function of the 
delay interval.  Two-way repeated measures ANOVA (exposure group x delay) revealed 
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a main effect of group [F(4,41) = 3.20, p < 0.05] and delay [F(6,246) = 65.7, p < 0.001].  
Rats exposed to 3 mg/kg amphetamine during adolescence were significantly impaired 
relative to rats exposed to the same dose during adulthood.  While there were no 
significant group differences in DNMTP performance, all rats showed a significant 
reduction in accuracy across delays [main effect of delay: F(6,246) = 39.2, p < 0.001].  
In addition, rats exposed to 1 mg/kg amphetamine during adolescence and both adult-
exposed groups required significantly more trials to reach criterion on DNMTP 
compared to DMTP [group x training phase interaction: F(4,246) = 3.00, p < 0.05].  
Follow-up analyses of proactive interference effects revealed that during DMTP training, 
rats were significantly more accurate on same compared to different trials, with rats 
exposed to 3 mg/kg amphetamine during adolescence particularly susceptible to 
proactive interference (Fig. 2.7).  The adolescent-exposed group was found to perform 
significantly worse than all other groups.  These effects were confirmed with a three-
way repeated measures ANOVA with significant main effects of group [F(4,41) = 3.30, p 
< 0.05], trial type [F(1,41) = 88.4, p < 0.001], and delay [F(6,246) = 64.4, p < 0.001].  
Separate analysis on different trials alone, revealed a significant group x delay 
interaction, with adolescents exposed to 3 mg/kg performing worse than control and 
adult-exposed groups [F(24,246) = 1.59, p < 0.05].  Analysis of proactive interference 
during DNMTP (data not shown) indicated that rats were less accurate on ‘different’ 
compared to ‘same’ trials [main effect of trial type: F(1,41) = 59.9, p < 0.001], but there 
were no statistically significant group differences in susceptibility to proactive 
interference.   
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Discussion 
The findings of the present study demonstrate long-lasting effects of 
amphetamine on cognitive performance that are dependent on the developmental time 
period during which drug exposure occurs.  Adult rats that were exposed to 
amphetamine during adolescence displayed delay-dependent deficits in choice 
accuracy, they required more sessions to optimize performance and learn task rules, 
and they were more susceptible to proactive interference, compared to control and 
adult-exposed groups.  Amphetamine-induced locomotor sensitization, however, was 
enhanced in adult- compared to adolescent-exposed rats.  Thus, amphetamine-induced 
changes in cognition were dissociable from the drug’s lasting effects on sensitivity to its 
motor activating effects.  Moreover, the enhanced vulnerability of adolescents to the 
disruptive effects of repeated amphetamine exposure in a medial PFC-sensitive 
cognitive task suggests that these age-dependent effects may be due to amphetamine-
induced disruptions in the normal development of the PFC.        
Our measures of amphetamine-induced activity in an open-field arena 
(Experiment 1) revealed similar psychomotor activation in adolescents and adults 
following an acute injection of 3 mg/kg amphetamine.  In addition, after ten intermittent 
injections of amphetamine, sensitization to the stereotypy-inducing effects of 
amphetamine were evident in both age groups, but this effect was greater in adult-
exposed rats, who also displayed a concomitant reduction in ambulation.  A similar 
pattern of ambulation was observed in both age groups following amphetamine 
challenge, although adult-exposed rats again showed more robust stereotypy than 
animals exposed to amphetamine during adolescence.  While it is possible that the 
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additional injections of amphetamine (0.3, 0.75 and 1.25 mg/kg) and ketamine (5, 7.5, 
and 10 mg/kg) rats received during DNMTP testing may have influenced the expression 
of their sensitized behavior following amphetamine challenge, all groups (including 
controls) had this same experience.  Inspection of the data shown in Fig. 1 reveals that 
the magnitude of amphetamine-induced activity in rats pre-exposed to saline (i.e., 
controls) was similar to that seen in adult-exposed rats during their first treatment.  
Thus, it’s unlikely that the drug challenges during the working memory task had 
differential effects among the groups.    
Age-dependent differences amphetamine-induced activity in rats and mice have 
been documented previously, with some studies showing that adults are more sensitive 
to acute amphetamine compared to adolescents (Mathews & McCormick, 2007; 
Mathews, Waters, & McCormick, 2009; Zombeck, Gupta, & Rhodes, 2009).  Others, 
however, report no age-dependent differences (Adriani, Chiarotti, & Laviola, 1998; 
Mathews & McCormick, 2007; Niculescu, Ehrlich, & Unterwald, 2005; Walker et al., 
2010).  There are also inconsistent findings for amphetamine-induced sensitization.  
Some studies report greater amphetamine-induced sensitization in adolescent-exposed 
rodents (Adriani et al., 1998; Kameda et al., 2011; Mathews, Morrissey, & McCormick, 
2010; Mathews, Kelly, & McCormick, 2011), whereas others indicate greater effects in 
adults (Good & Radcliffe, 2011; Richetto, Feldon, Riva, & Meyer, 2012; Zakharova, 
Leoni, Kichko, & Izenwasser, 2009) or no difference between age groups (Niculescu et 
al., 2005; Good & Radcliffe, 2011).  Methodological differences contribute to some of 
these discrepant findings, with key factors being amphetamine dose and the aspect of 
drug-induced behavior that is measured (e.g., locomotion or stereotypy).  At lower 
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doses (< 1.5 mg/kg), adolescents tend to show an attenuated response to the first 
injection but enhanced locomotor sensitization relative to adults (Bolanos, Glatt, & 
Jackson, 1998; Mathews & McCormick, 2007; Mathews et al., 2009; Zakharova et al., 
2009).  With higher doses (> 2 mg/kg), however, age-dependent differences in initial 
responsiveness diminish and repeated exposure produces robust stereotypy and 
reduced locomotor activity, particularly in adults, as shown here and elsewhere (Adriani 
et al., 1998; Adriani & Laviola, 2000).  Thus, adolescents appear to have a higher 
threshold for the psychomotor-activating effects of amphetamine, but once activated 
their response is similar to that seen in adults.  In addition, their qualitatively different 
pattern of sensitization following repeated exposure suggests the neuroadaptations 
induced by repeated amphetamine exposure may be unique in adolescents relative to 
adults.  Interestingly, age-dependent differences in amphetamine-induced behavior are 
often not observed unless subjects experience a period of withdrawal.  For example, 
sensitization is expressed following repeated amphetamine exposure during 
adolescence only when animals are challenged weeks later (Kolta, Scalzo, Ali, & 
Holson, 1990; McPherson & Lawrence, 2006).  Two potential explanations for this 
phenomenon are that amphetamine-induced neuroadaptations in adolescent-exposed 
animals are not evident until adulthood, or alternatively, that plasticity in younger 
animals is enhanced following an extended drug withdrawal period.  Dissociating these 
two hypotheses in rodents may prove difficult given the relative brevity of the adolescent 
time period.  Nevertheless, future studies are needed to elucidate the potential role that 
drug withdrawal plays in the age-dependent effects of amphetamine on plasticity and 
behavior.    
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In both Experiments 1 and 2, we observed age-dependent differences in the 
effects of amphetamine on working memory.  Rats exposed to 3 mg/kg amphetamine 
during adolescence, but not those exposed during adulthood, showed delay-dependent 
deficits in choice accuracy during DMTP training.  Analyses of proactive interference 
indicated the impaired performance of adolescent-exposed rats was largely due to 
decreased accuracy on different trials.  On these trials, their accuracy dropped to near 
chance at longer delays.  This floor effect may have contributed to the lack of group 
differences in overall accuracy at longer delays observed in Experiment 2.  
Nevertheless, rats exposed to amphetamine during adolescence in both experiments 
were more susceptible to proactive interference compared to control and adult-exposed 
animals.  Previous studies suggest that enhanced susceptibility to proactive interference 
reflects difficulties with encoding and organizing stimulus events and behavioral 
responses across trials.  Thus, accuracy is often worse on trials with incongruent stimuli 
and/or choices compared to previous trials (Dunnett, 1985; Dunnett & Martel, 1990; 
Edhouse & White, 1988; Paule et al., 1998).  In addition to the deficits in choice 
accuracy found within sessions, adolescent-exposed rats also required a greater 
number of sessions to reach performance criterion on both DMTP and DNMTP.  Age-
dependent differences in the rate of acquisition were only observed in Experiment 1.  In 
order to further explore the specificity of amphetamine exposure during adolescence 
and the degree of cognitive impairment from that exposure, Experiment 2 was 
performed with a few procedural changes.  
First, in order to better control for group differences in rearing environment and 
injection experience, rats in Experiment 2 were offspring of dams bred in our facility and 
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all animals received injections during both adolescence and adulthood.  Stress, 
particularly early in life, can have significant neurophysiological and behavioral 
consequences, especially with regards to the PFC and cognitive processes mediated by 
this brain region (Cerqueira, Mailliet, Almeida, Jay, & Sousa, 2007; Liston et al., 2006; 
Spear, 2009; Yuen et al., 2012).  The pre-exposure injections in Experiment 2 also 
began earlier in adolescence (P27) and young adulthood (P85) compared to those in 
Experiment 1 (P37 and P98 for adolescence and young adulthood, respectively).  
Second, the working memory task was altered such that a wider range of delay intervals 
was used and rats were required to perform a response at the nosepoke port on the 
chamber wall opposite to the sample before the choice phase began.  The former 
change was made because delay-dependent deficits in Experiment 1 were found at the 
longest delay interval tested (i.e. 24 s).  The requirement for a nosepoke response at 
the back wall of the chamber was implemented to further discourage the use of non-
mnemonic strategies (e.g., standing near the position of the sample lever during the 
delay phase), which may develop as task difficulty increases (Paule et al., 1998).  
Taken together, the results of these experiments suggest that intermittent exposure to a 
moderately high dose of amphetamine leads to cognitive dysfunction that is long-lasting 
and dependent on the age of exposure. 
  Interestingly, the deficits displayed by adolescent-exposed animals in the 
present study are similar to those observed in PFC-lesioned animals performing DMTP 
(Sloan et al., 2006).  There are numerous reports showing that damage to the medial 
PFC produces selective deficits in working memory performance, increased sensitivity 
to proactive interference, and impaired attention (Chudasama & Muir, 1997; Floresco, 
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Block, & Tse, 2008; Granon, Vidal, Thinus-Blanc, Changeux, & Poucet, 1994; Porter & 
Mair, 1997; Sloan et al., 2006).  Adolescent-exposed rats in the present study showed 
decreased accuracy and greater susceptibility to proactive interference that was most 
pronounced at delay intervals between 12 to 24 s.  Rats were not impaired at short 
delays, suggesting the deficits found here are due primarily to mnemonic dysfunction, 
rather than delay-independent disruptions in mediating behavior or attention.  However, 
attention deficits cannot be ruled out entirely because rats’ accuracy was susceptible to 
proactive interference, which requires attention allocated to the sample stimulus within 
each trial (Harper, Wisnewski, Hunt, & Schenk, 2005; White, 2001).  Given that 
adolescent-exposed rats were impaired on different trials at longer, and not shorter 
delays, suggests that if non-mnemonic deficits were induced by repeated amphetamine 
exposure, they were not significant enough to impair performance when task demands 
were relatively easier at short delays (Chrobak, 2008; Chudasama, 1997)  
A candidate mechanism for these effects of amphetamine is altered signaling in 
the mesocorticolimbic system.  Previous studies have found enhanced amphetamine-
induced plasticity in subcortical regions such as the hippocampus and striatum in 
adolescent animals (Ehrlich, Sommer, Canas, & Unterwald, 2002; Featherby, van den 
Buuse, Lubman, & Lawrence, 2008).  In addition, there is recent evidence that the PFC 
undergoes significant structural and functional plasticity with repeated exposure to 
amphetamines during this age period (Gramage, Del Olmo, Fole, Martin, & Herradon, 
2011; Lee, Kim, Lee, & Jang, 2011; Wong & Stevens, 2012).  Indeed, amphetamine 
produces unique age-dependent effects on glutamate and dopamine activity in the PFC 
(Good, Liang, Patel, & Radcliffe, 2011; Kindlundh-Hogberg, Blomqvist, Malki, & Schioth, 
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2008; Mathews et al., 2011), with significant changes in neuron excitability and 
dopamine release in animals exposed to the drug during adolescence (Gramage et al., 
2011; Laviola, Pascucci, & Pieretti, 2001; McPherson & Lawrence, 2006).  The 
importance of glutamate and dopamine systems in the performance of working memory 
tasks has been well documented (Baron, Wright, & Wenger, 1998; Enomoto & Floresco, 
2009; Valentim, Alves, Olsson, & Antunes, 2008).  In the present study, 
pharmacological manipulation of these systems with challenge injections of 
amphetamine and ketamine had differential effects on DNMTP performance.  Challenge 
injections of amphetamine dose-dependently reduced accuracy overall, while both 
drugs enhanced rats’ sensitivity to proactive interference.  Consistent with previous 
reports, rats’ performance was impaired on different trials following challenge with drugs 
that target dopamine and glutamate systems (Chrobak, Hinman, & Sabolek, 2008; 
Harper et al., 2005).  Additionally, the number of trial omissions and choice latencies 
were increased following drug challenge.  These findings suggest that rats may have 
become disoriented while performing the task and as a result they were more 
susceptible to proactive interference (Chrobak, 2008; Chudasama, 1997).  This 
hypothesis is further supported by studies showing that the organization of delay 
mediating behaviors and instrumental actions are disrupted by manipulations of 
dopamine and glutamate activity in the PFC (Baldwin, Sadeghian, & Kelley, 2002; 
Naneix, Marchand, Di Scala, Pape, & Coutureau, 2009).  Nonetheless, there were no 
differences in performance between controls and amphetamine-exposed groups 
following drug challenge.  Given that drug challenge occurred following extensive 
training, the lack of group differences is likely due to “overtraining” in the task.  At the 
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time of drug challenges, all animals were performing with similar accuracy despite the 
fact that they required, on average, more sessions to reach the 85% correct 
performance criterion.  Previous studies indicate that impairments in working memory 
and proactive interference following PFC lesions dissipate with training (Gisquet-Verrier 
& Delatour, 2006; Harrison & Mair, 1996; Koger & Mair, 1994).  Our findings are 
consistent with this notion.  Thus, while amphetamine-induced cognitive dysfunction 
persists over long periods of time, deficits may be overcome with extended training 
procedures.   
In conclusion, the results presented here suggest that repeated, intermittent 
exposure to amphetamine during adolescence has long-lasting consequences on drug 
sensitivity and cognitive function.  While previous studies from our lab and others have 
demonstrated the negative consequences of psychostimulant exposure during 
adolescence (Counotte et al., 2009; Hankosky & Gulley, 2012; Harvey et al., 2009; 
Vorhees et al., 2005; Wiley & Burston, 2010), the present findings indicate that repeated 
exposure to amphetamine at this age produces long-lasting mnemonic dysfunction.  
Thus, it is likely that age-dependent differences in cognitive dysfunction following 
repeated exposure to amphetamine are the result of unique and persistent 
neuroadaptations in animals still undergoing neural development.  Amphetamine-
induced dysfunction in the PFC may be an important mediating factor in the observed 
cognitive impairments.  This hypothesis will require further investigation, but it is 
noteworthy that adolescent development is marked by periods of altered receptor 
expression and signaling, increased synaptic pruning, and myelination in multiple brain 
regions, including the PFC (Andersen et al., 2000; Gould, Woolf, & Butcher, 1991; 
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Hamano et al., 1998; Kim & Juraska, 1997; Nunez, Nelson, Pych, Kim, & Juraska, 
2000; Spear, 2000).  Future studies employing neurophysiological and neuroanatomical 
methods are warranted to elucidate the specific neuroadaptations that accompany long-
term cognitive dysfunction in animals exposed to amphetamine during adolescence. 
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Table and Figures 
 
Table 2.1.  Effects of amphetamine (AMPH) and ketamine challenges on choice latencies and the number of trials omitted 
during the working memory task in Experiment 1.  Rats had a maximum of 10 s to respond on a lever during the choice 
phase before the trial was scored as an omission.  The omission data also include trials wherein rats failed to respond in ≤ 
10 s during the sample phase.  Numbers in parentheses indicate the number of rats/group.  ^^p < 0.001, compared to 
saline (omissions only, collapsed across exposure group); ***p < 0.01, compared to saline (latency and omissions, 
collapsed across exposure group). 
 
     
 AMPH (mg/kg)  Ketamine (mg/kg) 
Latency (s) Saline 0.3 0.75^^
 
1.25^^  Saline 5.0*** 7.5*** 10*** 
Control (n=16) 0.67 ±0.04 0.63 ±0.05 0.57 ±0.04 0.66 ±0.04  0.62 ±0.03 0.65 ±0.04 0.61 ±0.04 0.71 ±0.04 
Adolescent exposed (n = 15)  0.58 ±0.04 0.55 ±0.04 0.64 ±0.05 0.56 ±0.04  0.58 ±0.04 0.69 ±0.04 0.76 ±0.04 0.67 ±0.04 
Adult exposed (n = 19) 0.46 ±0.04 0.44 ±0.04 0.51 ±0.04 0.51 ±0.04  0.46 ±0.03 0.57 ±0.04 0.61 ±0.04 0.71 ±0.04 
          
Omissions (number/session)          
Control (n=16) 3.56 ±5.91 11.4 ±5.91 15.1 ±5.91 41.8 ±5.91  4.63 ±9.06 21.3 ±9.06 35.9 ±9.06 58.7 ±9.06 
Adolescent exposed (n = 15)  0.27 ±6.10 7.98 ±6.52 30.8 ±6.52 45.8 ±6.52  0.53 ±9.36 24.5 ±10.0 39.2 ±10.0 41.6 ±10.0 
Adult exposed (n = 19) 2.05 ±5.42 0.90 ±5.42 14.1 ±5.42 40.3 ±5.42  1.58 ±8.31 38.0 ±8.31 50.8 ±8.31 60.5 ±8.31 
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Figure 2.1.  Ambulatory activity and stereotypy (n = 15-19 rats/group) during the first 
(T1) and tenth (T10) saline or 3 mg/kg amphetamine (AMPH) treatment and after a 
challenge with 3 mg/kg AMPH, which was given after training and testing in the working 
memory task.  For ambulation (A), data are presented as the mean cumulative activity 
during the 60 min after injection.  For stereotypy, scores obtained every 5 min after 
injection were averaged to yield a single rating for the post-injection period.   ***p < 
0.001, compared to AMPH-exposed groups within treatment day; matching letters 
indicate significant differences (ambulation: p < 0.01; stereotypy: p < 0.01, for a,b,c,d,e 
and p < 0.05, for f,g).  
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Figure 2.2.  Performance on the working memory task in rats from Experiment 1 (n = 
15-19/group).  Shown in (A) and (B) is mean choice accuracy (% correct) within each 
delay block averaged across the first two training sessions that any rat achieved the 
performance criterion.  These were sessions 1-2 for DMTP and sessions 6-7 for 
DNMTP.  Shown in (C) is the mean number of sessions to reach a performance 
criterion (STC) of ≥ 85% correct choices for two consecutive sessions.  Matching letters 
indicate p < 0.001; ***p < 0.001 vs control and adult-exposed groups within delay; ###p < 
0.001 vs DNMTP, collapsed across exposure group. 
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Figure 2.3.  Proactive interference during DMTP training in rats from Experiment 1 (n = 
15-19/group).  Delay-dependent performance was assessed across delay blocks in 
trials that required either the same correct response (A) or a different correct response 
(B) compared to the choice made on the immediately preceding trial.  Shown are the 
group means within each delay block averaged across the first two training sessions on 
DMTP.  **p < 0.01 vs control; #p < 0.05 vs adult, within delay. 
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Figure 2.4.  Effects of challenge injections with (A) amphetamine (AMPH) or (B) 
ketamine on task performance in Experiment 1 (n = 15-19 rats/group).  Drugs were 
administered i.p. 5-10 min prior to the start of DNMTP sessions.  ***p < 0.001 vs 0 
(saline), collapsed across exposure group. 
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Figure 2.5.  Proactive interference during sessions following drug challenges in 
Experiment 1 (n = 15-19 rats/group).  Performance was assessed in trials that required 
either the same correct response or a different correct response compared to the choice 
made on the immediately preceding trial following (A and C) amphetamine (AMPH) and 
(B and D) ketamine.  Shown are the group means for each dose tested.  **p < 0.01 vs 0 
(saline), collapsed across exposure group. 
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Figure 2.6.  Performance on the working memory task in rats from Experiment 2 (n = 8-
10/group).  Data in (A) and (B) are presented as in Fig. 2.2  Because there were no 
significant effects of treatment on sessions to criterion (STC), data in (C) are plotted to 
emphasize differences in STC on DMTP compared to DNMTP.  Criterion performance 
was ≥ 85% correct for two consecutive sessions.  Matched letters indicated significant 
difference (p < 0.05); *p < 0.05 vs adult-exposed (3.0 mg/kg) group. 
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Figure 2.7.  Proactive interference during DMTP training in rats from Experiment 2 (n = 
8-10/group).  Data were analyzed and presented as in Fig. 2.3   #p < 0.05 vs adult (3.0) 
within delay; +p < 0.05 vs adult (1.0) within delay; *p < 0.05 vs control within delay.  
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Chapter 3.  Amphetamine exposure during adolescence alters behavioral and 
prelimbic neuron responses to dopamine receptor agonist and antagonist drugs 
in adulthood. 
 
 
 
Abstract 
Rationale: Repeated exposure to psychostimulants during adolescence produces 
long-lasting changes in behavior that may be mediated by disrupted development of the 
mesocorticolimbic dopamine system.  Here, we tested this hypothesis by assessing the 
effects of amphetamine (AMPH) and dopamine receptor-selective drugs on behavior 
and medial prefrontal cortex (PFC) neuron activity.  Methods: Adolescent rats were 
given saline or 3 mg/kg AMPH between postnatal day (P) 27 and P45.  In Experiment 1, 
locomotor behavior was assessed during adulthood following challenges with a 
dopamine D1 (SKF 82958) or D2 (quinpirole) receptor-selective agonist.  In Experiment 
2, pre-exposed rats were challenged during adulthood with AMPH and a D1 (SKF 
83566) or D2 (eticlopride) receptor-selective antagonist.  In Experiment 3, the activity of 
putative pyramidal cells in the prelimbic cortex was recorded as rats behaved in an 
open-field arena before and after challenge injections with AMPH and one of the 
antagonists.  Results: Compared to controls, adolescent pre-exposed rats were more 
sensitive to the stimulant effects of AMPH and the dopamine receptor agonists, as well 
as to the ability of the antagonists to reverse AMPH-induced stereotypy.  Prelimbic 
neurons from pre-exposed rats were also more likely to respond to AMPH, primarily by 
reducing their activity, and the antagonists reversed these effects.  Conclusions: 
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Exposure to AMPH during adolescence leads to long-lasting plasticity in the 
mesocorticolimbic dopamine system that likely mediates heightened response to the 
drug during adulthood and may also contribute to an increased incidence of cognitive 
dysfunction and substance use disorders in those who begin abusing drugs early in life.  
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Introduction 
 
Individuals with a long history of amphetamine (AMPH) misuse often exhibit 
impairments in tasks assessing executive cognitive functions such as impulse control, 
attention, working memory, and decision-making (McKetin and Mattick 1998; Ornstein 
et al. 2000; Woods et al. 2005; Monterosso et al. 2005; Casaletto et al. 2015).  Notably, 
however, cognitive impairment is not an inevitable consequence of repeated AMPH 
exposure (Scott et al. 2007; Hart et al. 2011) and the development of drug-induced 
cognitive dysfunction may depend on a number of ancillary factors.  One such potential 
factor is the initial age of drug exposure, with those beginning drug use during 
adolescence being most at risk.  This hypothesis is supported indirectly by data showing 
that brain regions known to be important for cognition, including those in the 
corticolimbic circuitry such as the prefrontal cortex (PFC), amygdala, and hippocampus, 
are among the last to develop adult-like structure and function, and appear highly 
susceptible to environmental influences such as drug use (Paus et al. 2008; Gulley and 
Juraska 2013).   In addition, cross-sectional analyses have suggested that those with 
the longest duration of psychostimulant abuse, which are individuals who started drug 
use in early adolescence, are the most susceptible to deficits in decision making 
(Rogers et al. 1999) and have a greater likelihood of developing a substance use 
disorder (Gilder et al. 2014; Wu and Schlenger 2003; Lopez-Quintero et al. 2011).  
Studies using non-human animal models, which can experimentally manipulate 
age-of-exposure, suggest that adolescents are at a heightened risk of developing long-
lasting cognitive dysfunction following chronic exposure to AMPH and other 
psychostimulants (Vorhees et al. 2005; Featherby et al. 2008; Harvey et al. 2009; 
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Counotte et al. 2011; Richetto et al. 2013; Hankosky et al. 2013; Hankosky and Gulley 
2013; Hammerslag et al. 2014; Ye et al. 2014).  For example, we recently demonstrated 
that rats given repeated, intermittent injections of 3 mg/kg AMPH showed delay-
dependent deficits on an operant delayed matching-to-position task after a protracted 
drug free period (Sherrill et al. 2013).  Notably, this working memory impairment was 
only found in animals that were given the drug during peri-adolescence.  The same 
schedule of intermittent injections did not influence the performance of a separate group 
of animals that were exposed to AMPH in adulthood (Sherrill et al. 2013). 
The mechanisms that underlie this enhanced vulnerability of adolescents to the 
adverse consequences of repeated AMPH exposure are uncertain, but a leading 
candidate is drug-induced changes in the normal development of the mesocorticolimbic 
dopamine system (Gulley and Juraska 2013).  Studies in rodents have demonstrated 
that during adolescent development, there are significant changes in the density of 
monoamine transporters and dopaminergic fibers (Kalsbeek et al. 1988; Moll et al. 
2000; Benes et al. 2000).  Dopamine neurons in the ventral tegmental area (VTA), 
which project to multiple areas including the PFC and nucleus accumbens (NAc), are 
more active during the adolescent period compared to adulthood and this appears to be 
due to a relatively reduced GABAergic tone in the adolescent VTA (McCutcheon et al. 
2012).  In addition, there is an overproduction and subsequent decline of dopamine D1 
and D2 receptor expression in the PFC and NAc as rats age from pre-adolescence into 
young adulthood (Andersen et al. 2000; Tarazi and Baldessarini 2000; Brenhouse et al. 
2008).  It has also been suggested that signaling via D1-D2 heteromers, particularly in 
the striatum and NAc, is also unique in adolescents compared to adults and this may 
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contribute to enhanced vulnerability in adolescents to the effects of abused drugs 
(Perreault et al. 2014).        
In the current study, we tested the hypothesis that repeated exposure to AMPH 
during adolescence leads to long-lasting changes in the function of D1 and D2 receptors 
in adulthood.  In Experiment 1, we investigated if adult rats pre-exposed to AMPH in 
adolescence were sensitized to the motor-activating effects of the D1-selective agonist 
SKF 82958 or the D2-selective agonist quinpirole compared to saline-treated controls.  
In a second experiment, we tested if the D1-selective antagonist SKF 83566 or the D2-
selective antagonist eticlopride would differentially influence AMPH-induced stereotypy 
in adolescent pre-exposed rats compared to controls.  Lastly, in Experiment 3 we used 
in vivo electrophysiology in adolescent pre-exposed rats and controls to investigate 
functional changes in putative pyramidal cells of the prelimbic region of the medial PFC.  
The activity of these output cells is tightly regulated by D1 and D2 receptors (Seamans 
and Yang 2004) and we recently found that adolescent AMPH exposure alters D1 
receptor-mediated inhibition in these cells in vitro (Kang et al. 2016a; Paul et al. 2016).        
 
Materials and Methods 
Subjects.  The male subjects (n = 96 for all experiments) were offspring of male 
and female Sprague-Dawley rats (Harlan, Indianapolis, IN, USA) bred in our animal 
facility.  Following weaning at postnatal day (P) 22, rats were housed 2-3 per cage with 
food and water available ad libitum.  Rats were maintained on a 12:12 hr light/dark cycle 
(lights on at 0800) and experimental procedures were conducted during the light phase.  
All experimental procedures were approved by the Institutional Animal Care and Use 
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Committee at the University of Illinois, Urbana-Champaign, and were in accordance with 
the Guide for the Care and Use of Laboratory Animals (National Research Council, 
2011). 
Open-field Apparatus.  Locomotor activity was monitored in open-field arenas (41 
x 41 x 41 cm) constructed of transparent acrylic walls and surrounded by photobeam 
frames (Coulbourn Instruments; Allentown, PA, USA) that recorded horizontal (lower 
frame; 2.5 cm above the arena floor) and vertical activity (upper frame; 15 cm above the 
arena floor).  Each open-field arena was housed in a sound-attenuating cubicle (76 x 80 
x 63 cm) that contained a 76 mm speaker fixed to one side wall to provide white noise 
(70 dB), two ceiling mounted white lights (4 W each), and a centrally mounted overhead 
camera (not used in this study).  Computer software (TruScan v 2.01, Coulbourn 
Instruments) was used to record photobeam breaks and to calculate ambulation (m), 
rearing (number), and stereotypy.  Stereotypy was measured as total number of 
repetitive movements, as defined by the recording software.   
Drugs.  D-amphetamine sulfate and SKF 82958 hydrobromide (D1 agonist) were 
purchased from Sigma-Aldrich (St. Louis, MO, USA).  SKF 83566 hydrobromide (D1 
antagonist), eticlopride hydrochloride (D2 antagonist), and (-) quinpirole hydrochloride 
(D2 agonist) were purchased from Tocris (Minneapolis, MN, USA).  All drugs were 
dissolved in sterile saline (0.9% NaCl).  Dosages were calculated based on the weight 
of the salt and given via intraperitoneal (i.p.) injection at a volume of 1 ml/kg.   
 Pre-treatment.  At weaning, rats were assigned to exposure groups so that 
animals from 12 litters were represented similarly across groups.  Cagemates (2-3 
rats/cage) were assigned to the same treatment groups; controls were given 0.9% 
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saline (1 ml/kg) and rats in the pre-exposed group were administered AMPH (3 mg/kg).  
Beginning on P27, one injection was given every other day for a total of 10 injections.  
For each injection, rats were transferred from the colony to a testing room, and placed 
individually into acrylic tubs (46 x 25 x 22 cm) lined with hardwood bedding where they 
remained undisturbed for 60 min post-injection. 
 
Experiment 1   
 
Approximately 30 days following their last pre-exposure injection (P70-P80), rats 
(n = 23) were transferred from the colony to a separate testing room where they 
remained in their homecages for a 30 min acclimation period.  Next, they were placed 
individually in an open-field arena for 15 min, then removed and injected with 1 ml/kg 
saline.  They were immediately returned to the open-field and 30 min later challenged 
with either a dopamine D1 (SKF 82958, 1.0 mg/kg) or a D2 (quinpirole, 0.5 mg/kg) 
receptor agonist.  Assignment of the specific agonist was made randomly.  Rats were 
allowed to behave undisturbed for 90 min and then were returned to their homecage.  
Three days later, the drug challenge procedure was repeated, but rats received the 
dopamine receptor agonist they did not get during the first drug challenge.  The order of 
drug challenges was counterbalanced within each group (i.e. control and pre-exposed).   
 
Experiment 2 
   
Approximately 30 days following the last pre-exposure (P70-P80), rats (n = 51) 
were given two challenge sessions that were separated by three days.  During the first 
session, rats were placed individually in an open-field arena for 15 min, then removed 
and injected with 1 ml/kg saline (Injection 1).  Thirty min later, they were administered 3 
83 
 
mg/kg AMPH (Injection 2) and allowed to freely move about the chamber for another 45 
min.  Lastly, rats were challenged (Injection 3) with saline, a dopamine D1 antagonist 
(SKF 83566, 0.03 mg/kg), or a D2 antagonist (eticlopride, 0.03mg/kg) and monitored for 
an additional 45 min.  This procedure was repeated three days later during a second 
session.  However, rats in the antagonist challenge groups were given the antagonist 
for Injection 3 that they did not receive during the first challenge session; the order of 
injections was assigned randomly.  Rats previously challenged with saline on session 
one received saline again for Injection 3.        
Data analysis for Experiments 1 and 2.  In Experiment 1, ambulation, stereotypy, 
and rearing measures were summed in 15-min bins and analyzed using separate two-
way ANOVAs, with time bin as the within-subjects factor and group (control, pre-
exposed) as the between-subjects factor.  Similarly, in Experiment 2, ambulation, 
stereotypy, and rearing measures were summed and analyzed using separate two-way 
ANOVAs with time bin as the within-subjects factor and between-subjects factors of 
group (control, pre-exposed).  Cumulative stereotypy, which was obtained for each rat 
by summing this measure for the 45-min period following injections with AMPH and 
challenge drugs (i.e., saline or the dopamine receptor antagonists), was analyzed with 
three-way mixed factor ANOVAs with injection as the within-subjects factor and 
between-subjects factors of group (control, pre-exposed) and challenge drug (saline, 
SKF 83566, eticlopride).  Main effects and interactions were further analyzed using 
Holm-Sidak multiple comparison procedures.  Statistical analyses were conducted using 
R Statistical Computing Software (R: a Foundation for Statistical Computing; Vienna, 
Austria) or Systat 11 (Systat Software Inc.; San Jose, CA, USA).   
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Experiment 3   
 
Rats (n = 5/group) underwent surgical procedures for implantation of microwire 
electrode arrays between P65 and P70 using methods we described previously (Gulley 
and Stanis 2010).  The array, which was implanted using stereotaxic coordinates for the 
prelimbic region of the medial PFC (3.0 mm AP, 0.7 mm ML, and 3.5mm DV to bregma; 
Paxinos and Watson 2007) consisted of eight Teflon-insulated stainless steel wires (50-
µm diameter each) arranged in a 2 x 4 pattern (NB Labs; Denison, TX, USA).  Rats 
were allowed to recover from surgery for ≥ 5 days.   
Between P70 and P80, which was approximately 30 days following the last pre-
exposure injection, rats were transferred from the colony to a separate testing room, 
where they remained in their homecages for a 30 min acclimation period.  During this 
time, voltage signals from each microwire were amplified with a unity gain field effect 
transistor (FET) headstage and transmitted via a shielded lightweight cable connected 
to a multi-channel commutator, which allowed the animal to freely move about the 
testing environment during recording sessions.  Extracellular signals were amplified, 
band-pass filtered (250 Hz to 8 kHz), and digitally captured with a 40 kHz sampling rate 
using a Multichannel Acquisition Processor (Plexon Inc.; Dallas, TX, USA).  Single-unit 
activity originating from putative pyramidal cells was identified based on waveform (i.e. 
spike) characteristics using well established criteria (Jung et al.; Barthó et al. 2004; 
Homayoun et al. 2005; Homayoun and Moghaddam 2006; Gulley and Stanis 2010).  
Spike sorting was also performed both online and offline from continuous data using 
both manual and automated procedures (Sort Client and Offline Sorter; Plexon Inc.).  
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Single-units were discriminated if the absolute refractory period of the target signal was 
> 1.1 ms and the waveform amplitude was at least 2.5:1 above background.    
Rats were subsequently placed into an open-field arena for 15 min, then 
removed and injected i.p. with 1 ml/kg saline.  Thirty minutes later, they were 
administered 3 mg/kg AMPH and allowed to freely move about the chamber for another 
45 min.  Lastly, they were injected with the D1 antagonist SKF 83566 (0.03 mg/kg, i.p.) 
and monitored for an additional 45 min.  During a second recording session, which took 
place two days after the first, the same procedure was used except the last injection 
given to rats was the D2 antagonist eticlopride (0.03mg/kg, i.p.). 
Experiment 3 data analysis.  Electrophysiological data were imported into 
NeuroExplorer (NEX Technologies, Madison, AL, USA) and analyzed with custom 
scripts and methods similar to those used previously in our lab and others (Homayoun 
and Moghaddam 2006; Gulley and Stanis 2010).  Neurons recorded during sessions 1 
and 2 were treated as independent units, although the anchoring of the electrode 
connectors to the skull leaves the possibility that the same or similar population of cells 
were sampled across sessions.  Baseline firing rates, which were designated as the 
mean activity (in Hz) during the saline phase of each recording session (15-min period 
after saline injection and before AMPH injection), were analyzed with two-way repeated 
measures ANOVA (group x session).  The 99% confidence interval for this baseline 
period was then used to classify each unit’s response to AMPH.  A unit was categorized 
as “increased” or “decreased” following AMPH if its activity post-injection was above or 
below, respectively, the 99% confidence interval for (1) five of the nine 5-min recording 
bins, or (2) at least four consecutive 5-min bins post-injection (Gulley and Stanis 2010).  
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Those units not meeting one of these criterion were classified as “not changed”.  The 
distribution of response types was compared between the control and pre-exposed 
groups using chi-square (χ2).   
To compare the magnitude change following AMPH challenge during sessions 1 
and 2 combined, mean firing rate was calculated for each unit in 5-min bins and activity 
was normalized to each unit’s baseline (mean firing during the 15-min saline injection 
period).  This was done by dividing the unit’s mean firing rate by its mean baseline firing 
rate and then expressing the value as a percentage.  These data were subsequently 
analyzed with separate two-way repeated measures ANOVAs (group x time) for 
increased and decreased response types.  The ability of D1 and D2 antagonists to alter 
AMPH-induced changes in firing rate were analyzed by comparing the mean normalized 
firing rate (% baseline) for the last 15 min of the AMPH injection interval to the last 15 
min of the antagonist response interval.  These data were then analyzed with separate 
two-way mixed factor repeated measures ANOVAs (group x injection) for each 
response type (increased or decreased) and antagonist (SKF 83566 or eticlopride).  For 
all ANOVA tests, main effects and interactions were further analyzed using Holm-Sidak 
multiple comparison procedures where appropriate. 
To analyze burst firing, spike train data were analyzed with the NeuroExplorer 
using the Poisson surprise method, which is robust against irregular patterns of activity 
and changes in mean firing rate that may obscure burst detection (Legéndy and 
Salcman 1985; Homayoun et al. 2005; Homayoun and Moghaddam 2006).  A minimum 
surprise value of 5 was set as the confidence level for detection.  For each unit, bursting 
rate (bursts/min) and the percent of spikes in bursts were compared between groups 
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using separate two-way repeated measures ANOVAs (group x injection).  Significant 
differences were followed-up with Holm post-hoc comparisons where appropriate.  
Statistical analyses for data obtained in Experiment 3 were conducted using SigmaPlot 
12.5 (Systat Software Inc.; San Jose, CA, USA).   
 
Results 
Experiment 1 – The effects of AMPH pre-exposure on D1 and D2 agonist challenge. 
Relative to baseline, there was an increase in motor activity following injection 
with the D1 agonist SKF 82958 in both controls and AMPH pre-exposed rats (Fig. 3.1).  
For ambulation, we found a significant main effect of time bin (F8,168 = 16.7, p < 0.001) 
and a significant group x time bin interaction (F8,168 = 6.30, p < 0.001).  As shown in Fig. 
3.1a, rats pre-exposed to AMPH had a significantly greater maximal response that 
persisted for the entire 90-min post-drug interval.  The D1 agonist also increased 
stereotypy (Fig. 3.1b) and rearing (Fig. 3.1c) behavior.  Separate ANOVAs indicated 
significant main effects of time bin for stereotypy (F8,168 = 5.79, p < 0.001) and rearing 
(F8,168 = 4.54, p < 0.001).  However, in contrast to ambulation, there were no significant 
main effects of group or group x time bin interactions (ps > 0.05).    
During challenge sessions with the D2 agonist quinpirole, rats pre-exposed to 
AMPH were more sensitive to drug-induced increases in ambulation (Fig. 3.2a).  Two-
way repeated measures ANOVA of these data revealed significant main effects of group 
(F1,21 = 6.76, p < 0.05) and time bin (F8,168 = 97.5, p < 0.001), as well as a significant 
group x time bin interaction (F8,168 = 4.97, p < 0.001).  Pre-exposed rats showed a 
significant increase in agonist-induced ambulatory activity beginning 30 min post-
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injection, while the activity of control animals did not significantly change across the 90 
min post-injection period.  Similarly, analysis of stereotypy (Fig. 3.2b) indicated a 
significant main effect of time bin (F8,168 = 22.3, p < 0.001) and a significant group x time 
bin interaction (F8,168 = 6.88, p < 0.001).  For rearing (Fig. 3.2c), there was a significant 
main effect of time bin (F8,168 = 10.1, p < 0.001) and a group x time bin interaction that 
was at the threshold for being considered statistically significant (F8,168 = 1.20, p = 
0.053).  Thus, for all three measures of motor activity, AMPH pre-exposed rats exhibited 
greater sensitivity to the effects of quinpirole.   
 
Experiment 2 – The effects of AMPH pre-exposure on AMPH and D1 or D2 antagonist 
challenge. 
In a separate group of rats, we assessed the effects of AMPH pre-exposure on 
the response to a challenge injection of AMPH and to subsequent injection with a D1 or 
D2 antagonist.  As shown in Figure 3.3, a challenge injection of 3 mg/kg AMPH 
significantly increased motor activity regardless of pre-exposure; however, AMPH pre-
exposed rats exhibited significantly less AMPH-induced ambulation than controls (Fig. 
3.3a).  A two-way repeated measures ANOVA on these data indicated significant main 
effects of group (F1,100 = 10.7, p < 0.01) and time bin (F5,500 = 179.9, p < 0.001), as well 
as a significant group x time bin interaction (F5,500 = 15.4, p < 0.001).  This relative 
reduction in ambulation was likely a result of response competition, as AMPH-induced 
stereotypy was significantly greater in pre-exposed rats relative to controls (Fig. 3.3b).  
Two-way repeated measures ANOVA of stereotypy indicated significant main effects of 
group (F1,100 = 33.6, p < 0.001) and time bin (F5,50 = 60.3, p < 0.001), as well as a 
significant group x time bin interaction (F5,500 = 10.6, p < 0.001).  Rearing behavior 
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followed a similar trend to ambulation, with pre-exposed rats rearing less than controls 
following AMPH (Fig. 3.3c).  Two-way repeated measures ANOVA on these data 
revealed significant main effects of group (F1,100 = 14.9, p < 0.001) and time bin (F5,500 = 
88.9, p < 0.001), and a significant group x time bin interaction (F5,500 = 20.4, p < 0.001).  
The effects of the dopamine receptor antagonists on AMPH-induced stereotypy 
were assessed following challenge injections with either saline, SKF 83566 (D1 
antagonist), or eticlopride (D2 antagonist).  As shown in Figure 3.4, the cumulative 
stereotypy response was greater in pre-exposed rats relative to controls, and continued 
to increase across the session in pre-exposed rats given saline at challenge.  In rats 
given SKF 83566 (Fig. 3.4a) or eticlopride (Fig. 3.4b) at this challenge injection, 
however, this continued increase in stereotypy across the session was blocked.  A 
three-way repeated measures ANOVA on these data indicated significant main effects 
of group (F1,96 = 8.09, p < 0.01) and challenge (F8,768 = 136.0, p < 0.001), and a 
significant group x challenge interaction (F16,768 = 1.71, p < 0.05).  There was no effect 
of challenge on stereotypy in controls that received saline during adolescence (p-values 
> 0.05). 
 
Experiment 3 – The effects of AMPH pre-exposure on medial PFC neuron activity. 
A total of 417 neurons were recorded from the medial PFC of control and AMPH 
pre-exposed rats (n = 5/group) during two open-field challenge sessions.  All electrodes 
were localized to the prelimbic region (Fig. 3.5a).  During baseline (15 min prior to 
AMPH injection), we found no significant differences in mean firing rate across the two 
recording sessions so these data were collapsed.  Moreover, the baseline activity of the 
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202 units recorded from controls (2.98 ± 0.18 spikes/sec) was not significantly different 
from that recorded in the 215 units from pre-exposed rats (3.17 ± 0.17 spikes/sec).   
Cells were classified as increased, decreased, or not changed based on 
modulations in firing rate following AMPH challenge (Fig. 3.5b).  In both control and 
AMPH pre-exposed rats, the majority of recorded prelimbic neurons (> 78%) were 
responsive to 3 mg/kg AMPH.  Of these AMPH-responsive units, the most frequent 
response-type was a decrease in firing rate post-injection (Fig. 3.5c).  We found a 
significant difference between groups in the population distribution of unit responses (χ2 
= 13.56, p < 0.01).  In pre-exposed animals relative to controls, there was a greater 
proportion of units that decreased firing rate after AMPH injection and a smaller 
proportion showing no change.  The percentage of cells excited by AMPH was similar in 
the two groups. 
Separate analyses of decreased and increased units revealed that the magnitude 
of change was greatest in the AMPH pre-exposed group (Fig. 3.6).  For decreased 
units, there were main effects of group (F1,226 = 8.12, p < 0.01) and time (F11,2486 = 
158.9, p < 0.001), as well as a group x time interaction (F11,2486 = 22.6, p < 0.001).  For 
increased units, there was a main effect of time (F11,1353 = 18.0, p < 0.001) and a group 
x time interaction (F11,1353 = 2.12, p < 0.05).  Between-group differences in response 
magnitude were significant by 20 min following AMPH injection and persisted for the 
duration of the recording period in units that had drug-induced decreases in firing rate 
(Fig. 3.6a).  For those with drug-induced increases (Fig. 3.6b), where responses in pre-
exposed rats were more variable, between-group differences were statistically 
significant by 25 min following injection.  
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At 45 min after they were administered AMPH, rats were given an injection of the 
D1-selective antagonist SKF 83566 (0.03 mg/kg) or the D2-selective antagonist 
eticlopride (0.03 mg/kg) to assess the ability of these drugs to alter AMPH-induced 
changes in medial PFC firing rate.  As shown in Figure 3.7, data were analyzed by 
comparing the mean normalized firing rate during the last 15 min of the 45-min AMPH 
response interval to the same measure during the last 15 min of the 45-min antagonist 
response interval.  For the D1 antagonist, we found a significant main effect of injection 
(F1,99 = 10.9, p = 0.001) and a near-significant main effect of group (F1,99 = 3.43, p = 
0.067) in decreased units (Fig. 3.7a); there was only a significant main effect of injection 
(F1,62 = 4.33, p < 0.05) for increased units (Fig. 3.7b).  For the D2 antagonist, we found a 
significant main effect of injection (F1,124 = 24.8, p < 0.001) and a near-significant main 
effect of group (F1,124 = 3.03, p = 0.084) in decreased units (Fig. 7a); none of the main 
effects or the interaction was significant for increased units (Fig. 3.7b).  Thus, both 
antagonists tended to reverse AMPH-induced changes in firing rate, but this effect was 
most robust for the D1-selective compound SKF 83566 in units that decreased firing rate 
after AMPH.  Moreover, the effect was similar in control and pre-exposed rats. 
In addition to the analysis of firing rate, burst firing activity of prelimbic neurons 
was also assessed during each recording session.  Separate two-way repeated 
measures ANOVAs for bursting rate revealed significant main effects of injection during 
both sessions (SKF 83566: F2,400 = 15.5, p < 0.001; eticlopride: F2,436 = 40.5, p < 0.001) 
and a significant group x injection interaction (F2,400 = 4.38, p < 0.05) for the first session 
when the D1 antagonist was administered.  As shown in Figure 3.8a, spontaneous 
bursting following saline injections in the first test session was blunted in pre-exposed 
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animals relative to controls.  This effect of pre-exposure was evident in the second test 
session (Fig. 3.8b), but the group difference was reduced and not statistically 
significant.  In both sessions, bursting rate tended to decrease following injections of 3 
mg/kg AMPH, particularly in controls.  AMPH-induced reductions in bursting rate were 
relatively unaffected by challenges with either antagonist.     
Analysis of the percentage of spikes occurring in bursts also revealed effects of 
AMPH and antagonist challenges, but these varied depending on the recording session.  
In the session where the D1 antagonist was tested, we found a significant group x 
injection interaction (F2,400 = 4.00, p < 0.05).  As shown in Figure 3.8c, prelimbic units 
recorded from pre-exposed rats had in increase in the percentage of spikes occurring in 
bursts following AMPH injection and this was reversed following injection with the SKF 
83566.  In the session where the D2 antagonist was tested, we found a significant main 
effect of time (F2,436 = 14.0, p < 0.001), and a near significant group x injection 
interaction (F2,436 = 2.97, p = 0.052).  Thus, in both groups there was a significant 
increase in the percentage of spikes occurring in bursts and this effect was reversed to 
a statistically significant extent in the pre-exposed group of rats. 
 
Discussion 
The developing dopamine system of the adolescent brain may be an especially 
vulnerable target of the plasticity induced by repeated drug exposure.  In the current 
study, we tested the hypothesis that AMPH exposure during adolescence induces 
changes in dopamine receptors that would persist into adulthood, lead pre-exposed rats 
to be more sensitive to the behavioral effects of AMPH and dopamine receptor-selective 
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drugs, and alter the function of putative pyramidal cells in the prelimbic region of the 
medial PFC.  In Experiment 1, we found that AMPH pre-exposed rats, compared to 
controls, were more sensitive to the motor activating effects of the D1 agonist SKF 
82958 and the D2 agonist quinpirole.  With the D1 agonist, this sensitization was isolated 
to ambulation, whereas the D2 agonist induced a relatively greater effect on both 
ambulation and stereotypy.  In Experiment 2, we found that pre-exposed rats were more 
sensitive to the stereotypy-inducing effects of AMPH as well as to the ability of a D1 or 
D2 antagonist to attenuate AMPH-induced stereotypy.  Lastly, our electrophysiological 
recordings of prelimbic neurons (Experiment 3) revealed that cells recorded from pre-
exposed rats, compared to those from controls, were less likely to be firing in bursts 
under baseline conditions.  Following an AMPH challenge, these neurons were also 
more likely to be inhibited by AMPH, they exhibited a greater magnitude of change from 
baseline firing, and they were more sensitive to D1 and D2 antagonist-induced reversal 
of AMPH’s effects on burst firing.  Together, these results support the hypothesis that 
AMPH exposure during adolescence alters the development of the dopaminergic 
system, and in particular D1 and D2 receptor function, such that in adulthood animals 
are more sensitive to the neural and behavioral effects of drugs that influence dopamine 
receptor function.  
It has been known for some time that rats pre-exposed to AMPHs in adulthood 
will exhibit behavioral sensitization to D2, but not D1, receptor-selective agonists 
following long withdrawal periods (Levy et al. 1988; Ujike et al. 1990; Vanderschuren et 
al. 1999).  Here, we show that AMPH exposure during adolescence leads to a 
sensitized response to both D1 and D2 receptor-selective agonists when challenges are 
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given in adulthood.  This suggests that drug exposure during adolescence, which is a 
developmental stage when these receptors are overproduced and subsequently pruned 
(Tarazi and Baldessarini 2000; Andersen et al. 2000; Brenhouse et al. 2008), may lead 
to unique changes in dopamine receptor expression and/or function compared to when 
drug exposure occurs during adulthood.  Supporting this hypothesis, we recently 
showed that the same AMPH exposure protocol we used here induced a reduction of D1 
expression in the medial PFC (Kang et al. 2016b) and inhibited D1 receptor-mediated 
inhibition of pyramidal cell output in the medial PFC (Kang et al. 2016a) when assessed 
in adulthood.  Also consistent is our current finding that adult rats exposed to AMPH 
during adolescence were more sensitive to the effects of dopamine receptor-selective 
antagonists on AMPH-induced stereotypy.   
Previous work revealed that when AMPH-exposed adolescents were given an 
AMPH challenge in adulthood, they exhibit sensitized locomotor responses (McPherson 
and Lawrence 2006; Mathews et al. 2011; Labonte et al. 2012; Richetto et al. 2013; 
Shanks et al. 2015) and stereotypy (Sherrill et al. 2013; Hankosky et al. 2013).  
However, it was not previously demonstrated that dopamine receptor antagonists could 
partially reverse this sensitized response in adolescent-exposed rats or that D1 and D2 
receptor-selective antagonists were similarly efficacious.  Activation of D1, and to a 
lesser extent D2 receptors, is known to be important for the induction of AMPH 
sensitization (Ujike et al. 1989; Vezina 1996; Meng et al. 1998; Karper et al. 2002; 
Tanabe et al. 2004; Tournier et al. 2013; Kai et al. 2015), but their relative roles in its 
expression have been less well characterized.  The fewer number of studies 
investigating expression have analyzed adult-exposed rats following relatively short 
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withdrawal periods (≤ 14 days) and suggest a more prominent role for D1 receptors 
(Shuto et al. 2006; Shi and McGinty 2011) or a D1-D2 heteromer (Shen et al. 2015).  
The current findings are suggestive of an enhanced sensitivity of the developing 
adolescent brain to the ability of AMPH to induce enduring changes in the function of D1 
and D2 receptors in the PFC, though this hypothesis will require further investigation 
with comparison groups of subjects that are outside the window of adolescent 
development when they are exposed to the drug (e.g., juveniles and adults).     
Our electrophysiology results suggest that AMPH-induced adaptations in the 
prelimbic cortex play a role in the behavioral adaptations we observed.  Previously, 
neurons in the prelimbic and infralimbic regions of the medial PFC from AMPH-exposed 
adult rats were shown to be more responsive to AMPH compared to those recorded 
from controls when a challenge injection was given following a short withdrawal 
(Homayoun and Moghaddam 2006; Gulley and Stanis 2010).  In these studies, which 
like the current experiments were done in freely behaving rats, the effects of AMPH pre-
treatment differed depending on dose and withdrawal duration.  In the earlier study 
(Homayoun and Moghaddam 2006), adult rats were treated for 5 days with 2 mg/kg 
AMPH or saline and were subsequently given a 2 mg/kg AMPH challenge following a 
10-day withdrawal period.  The authors reported that compared to controls, neurons 
from AMPH pre-exposed rats were more responsive to the challenge injection and the 
most frequent response observed was an inhibition in firing.  In experiments from our 
laboratory (Gulley and Stanis 2010), adult rats were treated with 1 mg/kg AMPH for 5 
days and challenged with the same dose following a 4-day withdrawal.  Like the earlier 
study, AMPH pre-exposed rats were more responsive to AMPH and the predominant 
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effect was a decrease in firing rate and bursting.  Here, where exposure to a higher 
dose of AMPH (3 mg/kg) occurred during peri-adolescent development and the AMPH 
challenge was given ~30 days later in adulthood, we observed a similar predominance 
of AMPH-induced decreases in firing rate.  Additionally, we found that the prelimbic 
neurons from AMPH pre-exposed rats were more sensitive to D1 and D2 antagonist-
induced reversal of AMPH’s effects on burst firing, though the ability of these 
antagonists to reverse changes in firing rate were similar in pre-exposed and control 
rats.  A similar reversal of AMPH’s effects on neural activity in behaving rats was 
previously reported in recordings from dorsal striatum (Rosa-Kenig et al. 1993).  
Together, the previous and current findings suggest that the longer-term adaptations in 
medial PFC circuitry that AMPH induces likely involve changes in the sensitivity of D1 
and D2 receptors and they may be more pronounced following adolescent exposure or a 
more protracted withdrawal period.  Differentiating between these hypotheses of age or 
withdrawal duration dependency requires future studies, but our previous in vitro 
electrophysiology findings support the important role of exposure age for determining 
the effects of AMPH exposure on PFC neuronal physiology (Kang et al. 2016a; Paul et 
al. 2016). 
In summary, the results of the current study and others (Laviola et al. 2001; 
McPherson and Lawrence 2006; Labonte et al. 2012; Reynolds et al. 2015; Kang et al. 
2016b; Tendilla-Beltrán et al. 2016) point to a key role for drug-induced changes in the 
structural and functional development of the mesocorticolimbic dopamine system in the 
neural and behavioral changes induced by adolescent AMPH exposure.  One intriguing 
possibility, which awaits testing, is that the phasic dopamine changes caused by an 
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injection of AMPH have the unique ability to reorganize the structural and functional 
connections between the ventral tegmental area and the PFC in adolescents compared 
to adults.  A recent optogenetic study revealed this potential mechanism for heightened 
mesofrontal circuit plasticity in adolescents compared to adults and further 
demonstrated that D2 receptors play an important role in regulating this plasticity 
(Mastwal et al. 2014).  Dopamine systems are undoubtedly not alone in being affected 
by AMPH, however, and long-lasting changes in GABAergic (Cass et al. 2013), 
glutamatergic (Counotte et al. 2011) and cholinergic (O’Dell 2009) functioning have also 
been reported following exposure to AMPHs and other psychostimulants during 
adolescence.  An important goal of future studies will be to more specifically link drug-
induced disruptions with the consequences they induce, especially those related to 
cognitive dysfunction and other behaviors known to be critically involved in addiction.  It 
will also be important to provide more detailed analysis of the developmental timing of 
drug exposure as multiple recent studies have revealed that drug exposure during 
specific times during peri-adolescence can influence later neurophysiological and 
behavioral outcomes (Adriani et al. 2004; Kang et al. 2016b; Tendilla-Beltrán et al. 
2016) and that puberty may influence drug effects on neuronal development differently 
in males and females (Drzewiecki et al. 2016; Juraska and Willing 2016). 
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Figure 3.1  Ambulation (a), stereotypy (b) and rearing (c) in an open-field arena 
following challenge with 1.0 mg/kg SKF 82958 (n = 11-12/group).  Arrows indicate time-
bins when rats were removed from the open-field and injected (i.p.) with saline and the 
D1 agonist.  *p < 0.05,
 **p < 0.01 vs baseline (45-min bin) within group; #p < 0.05 vs 
control within time bin; @p < 0.05 vs baseline collapsed across group 
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Figure 3.2.  Ambulation (a), stereotypy (b) and rearing (c) in an open-field arena 
following challenge with 0.5 mg/kg quinpirole (n = 11-12/group).  Arrows indicate time-
bins when rats were removed from the open-field and injected (i.p.) with saline and the 
D2 agonist.  *p < 0.05, **p < 0.01 vs baseline (45-min bin) within group; 
#p < 0.05 vs 
control within time bin; @p < 0.05 vs baseline collapsed across group 
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Figure 3.3.  Ambulation (a), stereotypy (b) and rearing (c) in an open-field arena 
following challenge with 3.0 mg/kg AMPH.  Arrows indicate time-bins when rats were 
removed from the open-field and injected (i.p.) with saline and AMPH.  Data are 
presented collapsed across antagonist treatment group for pre-exposed rats (n = 25) 
and controls (n = 26).  #p < 0.001 vs control within time bin, **p < 0.001 vs baseline (45-
min bin) within group 
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Figure 3.4.  Stereotypy following 3.0 mg/kg AMPH and challenge injections of saline, 
0.03 mg/kg SKF 83566 (a) or 0.03 mg/kg eticlopride (b).  Data are presented as the 
cumulative response for the entire 45-min post-injection interval (n = 8-9/group).  ***p < 
0.001 vs AMPH period within group; #p < 0.05 vs pre-exposed rats given a saline 
challenge 
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Figure 3.5.  Putative pyramidal neurons from the prelimbic cortex that responded to a 
3.0 mg/kg AMPH injection with an increase (+), decrease (-) or no change (NC) in firing 
rate.  (a) A total of 417 recordings were made from electrodes implanted in the prelimbic 
region of the medial PFC.  Closed circles represent approximate electrode tip locations 
for AMPH pre-exposed rats, whereas open circles represent locations for controls (n = 5 
rats/group).  Numbers indicate the distance anterior to bregma (images adapted from 
Paxinos and Watson 2007).  (b)  Representative examples of each type of unit 
response (see Methods for classification procedure).  Data are mean firing rate in 5-min 
bins during a 15-min saline injection baseline and 45 min after AMPH injection (t = 0 
min).  (c) The population distribution of categorized units recorded from control and pre-
exposed rats.  The number of cells in each category is given in parentheses.  Because 
there were no significant differences in the distribution of response types between 
recording sessions, data are presented collapsed across sessions.  **p < 0.01, χ2 
statistic comparing proportion of responses in control and pre-exposed groups   
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Figure 3.6.  Magnitude of firing rate changes in prelimbic cortex cells classified as 
decreasing (a) or increasing (b) following a challenge injection of 3.0 mg/kg AMPH 
(designated by the arrow).   Data are normalized to the pre-injection baseline for each 
unit. *p < 0.05, **p < 0.01, and ***p < 0.001, vs. the last time bin before AMPH injection 
(t = 45 min) within group; #p < 0.05 vs. pre-exposed group within time bin  
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Figure 3.7.  Magnitude of firing rate changes in decreased (a) and increased (b) cells 
during the last 15-min of the 45-min recording period following 3.0 mg/kg AMPH 
injection and the last 15 min of the 45-min recording period following the D1 antagonist 
SKF 83566 (0.03 mg/kg) or the D2 antagonist eticlopride (0.03 mg/kg).  Data are 
normalized to the pre-injection baseline for each unit.   
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Figure 3.8.  Burst firing during saline baseline (SAL), following 3.0 mg/kg AMPH, and 
after challenge with the D1 antagonist (SKF 83566; panels a, c) or the D2 antagonist 
(eticlopride; panels b, d).  Matching letters indicate significant between or within-group 
differences (p < 0.05).  ***p < 0.001 vs SAL, collapsed across group 
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Chapter 4.  General Discussion 
 
The objectives of this dissertation were threefold.  The first was to identify if 
repeated exposure to AMPH has long-lasting effects on behavior supported by the 
medial PFC.  The second was to determine if exposure to AMPH during adolescence 
produces outcomes distinct from those occurring when exposure occurs during 
adulthood.  The last objective was to assess the impact of AMPH exposure during 
adolescence on dopamine receptor function and medial PFC neuron activity later in life.  
Findings described in Chapter 2 indicate that repeated exposure to AMPH has a long-
lasting impact on psychomotor activity and working memory function.  Interestingly, both 
adult- and adolescent-exposed animals displayed sensitization after extended drug-free 
periods, although, only rats given AMPH during adolescence showed impaired 
performance on the delayed matching to position task (DMTP).  These results suggest 
that there is an age-dependent dissociation between the long-term effects of AMPH on 
adolescent and adult animals.  The results described in Chapter 3 are consistent with 
the findings from Chapter 2, showing that animals exposed to AMPH during 
adolescence display long-lasting sensitization to AMPH.  Additionally, those 
experiments indicate that adolescent-exposed animals have greater sensitivity to 
dopamine D1 and D2 receptor-selective drugs and display distinct differences in medial 
PFC neuron activity relative to drug-naïve animals.  These neuroadaptations are likely 
to contribute to the behavioral outcomes associated with adolescent drug exposure and 
implicate the PFC and the interconnected mesocorticolimbic circuit as a target of 
enhanced plasticity during adolescence.  
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The PFC is part of an extended mesocorticolimbic network that plays a 
significant role in cognition and goal-directed behavior (Kolb 1984; Fuster 1993; 
Robbins and Arnsten 2009).  On the bases of anatomical, neurochemical, and 
behavioral distinctions, the PFC is separable into medial and lateral subterritories, each 
with further subdivisions and numerous connections with other cortical and subcortical 
regions.  In the rat, the medial PFC can be subdivided into a dorsal region, which 
includes the precentral (PrCm) and anterior cingulate (AC), and a ventral region 
comprised of the prelimbic (PL), infralimbic (IL) and medial orbital (MO) cortices 
(Leonard 1969; Krettek and Price 1977; Freedman and Cassell 1991; Granon et al. 
2000; Heidbreder and Groenewegen 2003; Kesner and Churchwell 2011).  Medial PFC 
subregions share reciprocal connections and also project to other cortical and 
subcortical areas involved in affective and sensory-motor processing.  The major 
projections of the dorsal medial regions (AC/PrCm) are to dorsal striatum and various 
thalamic areas.  The ventral medial PFC (PL/IL-MO) also shares connections with 
striatum and thalamus, but also sends efferents to the hypothalamus, amygdala, ventral 
tegmental area (VTA), and the core and shell of the nucleus accumbens (McGeorge 
and Faull 1989; Sesack et al. 1989; Hurley et al. 1991; Berendse et al. 1992; Bates and 
Goldman-Rakic 1993; Gorelova and Yang 1997; Seamans et al. 2001; Ding et al. 2001; 
Hoover and Vertes 2007).   
 The efferent projections of the medial PFC are primarily glutamatergic pyramidal 
cells, while its afferents are from more neurochemically diverse cells (Sesack et al. 
1989; Hurley et al. 1991; Condé et al. 1995; Fisk and Wyss 1999).  The medial PFC 
receives dense dopaminergic and GABAergic afferents from the VTA and projects back 
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to the midbrain with excitatory efferents (Lindvall et al. 1978; Beckstead et al. 1979; 
Pirot et al. 1992; Carr and Sesack 2000; Lewis and O’Donnell 2000).  The medial PFC 
also receives glutamatergic inputs from the hippocampus and amygdala (Carr and 
Sesack 1996; Gabbott et al. 2002; Floresco and Grace 2003).  These afferents form 
synapses on medial PFC pyramidal output neurons as well as local GABAergic 
interneurons (McDonald 1991; Condé et al. 1995; Mcdonald et al. 1996; Bacon et al. 
1996; Gabbott et al. 2006).  As such, afferent connections with the medial PFC may 
have an excitatory or inhibitory effect on local neuronal activity (Sesack et al. 1995; 
Mulder et al. 1997; Le Moine and Gaspar 1998; Floresco and Tse 2007).  
While the striatum and VTA have received the most attention for their role in 
psychostimulant activity and sensitization, the PFC also plays a prominent role 
(Steketee 2003).  The PFC exerts “top-down” control over subcortical neural circuits; 
signaling within and between limbic structures is influenced directly or indirectly by the 
PFC.  For example, electrical stimulation of the medial PFC has the potential to directly 
excite or inhibit neurons within the ventral striatum via glutamatergic efferents 
(O’Donnell and Grace 1993, 1994) or indirectly via efferents to the hippocampus and 
VTA (Carr and Sesack 2000; Goto and O’Donnell 2002; Belujon and Grace 2008).  Just 
as medium spiny neurons in the striatum display changes in excitatory activity following 
AMPH treatment (Haracz et al. 1989; Rosa-Kenig et al. 1993), so do pyramidal cells in 
the medial PFC (Gulley and Stanis 2010).  Furthermore, cortical lesions attenuate 
AMPH-induced behavior and excitatory activity in the striatum (Tschanz et al. 1991; 
1994).  Dopamine transmission plays an integral role in signaling between limbic 
structures and the PFC (Pycock et al. 1980; Broersen et al. 1995; Cohen et al. 2002; 
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French and Totterdell 2002; Chudasama and Robbins 2004; Arnsten and Pliszka 2011).  
Top-down control exerted by the medial PFC is modulated by afferent dopamine 
projections (Granon et al. 2000; Hitchcott et al. 2007).  Stimulation of dopamine neurons 
in the VTA increases extracellular concentrations of dopamine at terminals in the medial 
PFC and may inhibit local neural activity (Garris et al. 1993; Jay et al. 1995; Lewis and 
O’Donnell 2000).  However, changes in mPFC activity depend on the location of 
synaptic terminals.  Stimulation of dopamine D1 receptors located on pyramidal cells 
tends to increase PFC neural activity (Henze et al. 2000; Lavin et al. 2005), whereas 
stimulation of D1 receptors on local GABAergic interneurons produces inhibition 
(Seamans et al. 2001). 
 Dopamine signaling via D1 and D2 receptors is particularly important for both the 
acute and long-lasting effects of AMPH on psychomotor activity.  Previous studies show 
that sensitization is blocked in adult animals administered dopamine D1 or D2 receptor 
antagonists prior to AMPH (Ujike et al. 1989; Vezina and Stewart 1989; Wolf and Xue 
1999; Hall et al. 2009), and here we report attenuated expression of sensitization 
following adolescent AMPH exposure.  AMPH produces age-dependent effects on 
glutamate and dopamine activity in the PFC (Kantak et al. 2007; Kindlundh-Hogberg et 
al. 2008; Mathews et al. 2011), and significant changes in neuron excitability and 
neurotransmitter release in animals exposed to the drug during adolescence (Laviola et 
al. 2001; McPherson and Lawrence 2006; Gramage et al. 2011).  Excitatory activity of 
PFC pyramidal cells is tightly regulated by inhibitory GABAergic interneurons.  During 
adolescence, inhibitory functioning in the PFC is reduced and dopamine receptors are 
in flux (Sturman and Moghaddam 2011; Brenhouse and Andersen 2011).  Notably, D1 
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and D2 receptors play a necessary role in this synaptic regulation.  In an elegant set of 
recent experiments, repeated AMPH exposure during adolescence was found to reduce 
D1 signaling and receptor expression in the medial PFC (Kang et al. 2016a; 2016b).  
These neuroadaptations were accompanied by attenuated inhibitory signaling later in 
adulthood.  This may explain some of the changes in excitatory activity of pyramidal 
neurons recorded in the experiments described here.  Interestingly, pharmacological 
manipulation of D1 receptors following chronic exposure to AMPH has been shown to 
reverse cognitive dysfunction and neurophysiological adaptations in adult animals 
previously sensitized to the drug (Fletcher et al. 2007; Selemon et al. 2010).  
Nonetheless, D2 receptors located on presynaptic interneurons also contribute to 
excitatory activity of pyramidal cells in the PFC.  Given that rats pre-exposed to AMPH 
showed sensitivity to both D1 and D2 receptor selective drugs during young adulthood, 
neuroadaptations in D2 signaling and receptor expression will be important to assess in 
future studies. 
In recent decades awareness of the social problems and adverse health risks 
related to the pandemic abuse of AMPH has grown (Ujike et al. 1989; Sommers et al. 
2006; Berman et al. 2009; Ho et al. 2009).  Of particular concern, is accumulating 
evidence linking chronic AMPH abuse with psychological dysfunction (Scott et al. 2007; 
Grelotti et al. 2010; Dean et al. 2013).  Epidemiological data indicate that adolescence 
is a time period associated with heightened vulnerability for the onset of psychiatric 
disorders including mood disorders, schizophrenia, and substance (Volkmar 1996; 
Grant and Dawson 1997; Pine 2002; Chambers et al. 2003; Casey et al. 2005).  One of 
the core behavioral symptoms associated with these disorders is cognitive dysfunction, 
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while altered PFC function may be a unifying substrate.  Previous studies show 
widespread structural and functional adaptations in the PFC following repeated AMPH 
treatment, with significant changes in dendritic complexity, neuronal excitability, and 
dopamine release (Heitz et al., 2003; Kindlundh-Hopberg et al., 2008; Gramage et al., 
2011; Lee et al., 2011; Wong & Stevens, 2012).  The findings presented here add to this 
collective, showing that exposure to AMPH during adolescence has a lasting impact on 
dopamine D1 and D2 receptor function and medial PFC neuron activity.  It is not clear 
from these studies if the long-lasting effects of AMPH on the behavior of adolescent-
exposed animals is solely a result of neuroadaptations in the PFC.  It is unlikely that 
plasticity in only one node of the mesocorticolimbic circuit is responsible for the 
behavioral impact of AMPH.  Indeed, evidence is accumulating that multiple areas in the 
mesocorticolimbic system undergo plasticity with AMPH exposure during adolescence.  
For example, the neural activity of VTA dopamine neurons remains altered in adult 
animals long after they were exposed to the drug during adolescence (Laviola et al. 
2001; Labonte et al. 2012).  Nonetheless, neuroadaptations in the PFC following 
repeated drug exposure during adolescence may be the primary substrate of cognitive 
dysfunction later in life. 
Repeated exposure to AMPH has a robust and long-lasting effect on cognitive 
function (McKetin and Mattick 1997; 1998; Fletcher et al. 2005; Floresco and Whelan 
2009).  In both clinical and preclinical settings, the impairments associated with chronic 
AMPH exposure overlap with cognitive deficits found after damage or disruption of the 
PFC (Rogers et al. 1999).  The medial PFC mediates attention and working memory 
functions necessary for appropriate decision-making and goal-directed behavior 
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(Mackintosh 1975; 1976; Honig and Thompson 1982).  Previous studies indicate that 
chronic exposure to AMPH alters cellular structure and activity in the medial PFC 
(Robinson and Kolb 1997; Gulley and Stanis 2010).  AMPH-induced plasticity in the 
medial PFC and corticolimbic circuitry is thought to mediate cognitive dysfunction 
associated with chronic exposure to the drug.  Studies employing in vivo 
electrophysiology techniques have revealed that neurons in corticolimbic brain regions 
encode reinforcers, actions, and reward-paired stimuli (Nishijo et al. 1988; Apicella et al. 
1991; Carelli and Deadwyler 1994; Schultz 2001; Hölscher et al. 2003; Roitman et al. 
2005; Homayoun and Moghaddam 2006; Totah et al. 2009) and point to the medial PFC 
as a critical node within an extended network that functions to guide goal-directed 
behavior.  Disruptions of medial PFC functioning lead to perseverative/habitual behavior 
(Killcross and Coutureau 2003; Marquis et al. 2007; Naneix et al. 2009; Furlong et al. 
2010), and neurons within the medial PFC are activated during goal-directed behavior 
and serve to encode and update reward-related information (Homayoun and 
Moghaddam 2006; 2009).  As shown here, AMPH given during adolescence impairs 
choice accuracy in the DMTP task.  This effect is likely due to deficits in attention to 
sample stimuli and/or impairment in working memory function (Bushnell and Levin 1993; 
Stefani and Moghaddam 2002; Harper et al. 2005).  Deficits on DMTP may be also 
related to issues of response inhibition, perseveration and cognitive flexibility.  The 
relationship between working memory performance and flexibility has been described 
previously (Grégoire et al. 2012) and is noteworthy given recent reports from our lab 
showing that AMPH exposure during adolescence has a lasting and detrimental effect 
on cognitive flexibility and response inhibition (Hankosky et al. 2013; Hankosky and 
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Gulley 2013; Hammerslag et al. 2014).  Nevertheless, while many reports indicate 
deficits in attention, decision-making, working memory, and reward-related learning, 
others find no change, or enhanced performance on cognitive tasks following drug 
exposure during adolescence (Kantak et al. 2014; Kirschmann et al. 2016; Spear 2016).  
Differences in drug dosing and other methodological discrepancies are likely to account 
for some of these conflicting findings (Grilly and Loveland 2001; Berman et al. 2009; 
Gulley and Juraska 2013).  In addition, rearing history and the age at which animals are 
exposed to drugs are often not well controlled and many studies fail to describe the age 
of experimental animals during various stages of drug exposure, or carry out 
experiments with animals exposed to drugs and tested during adulthood.   
The studies discussed in this dissertation demonstrate age-dependent effects of 
AMPH on behavior and suggest that adolescent exposure leads to long-lasting plasticity 
in the mesocorticolimbic system.  One limitation of these studies is that the experiments 
were all performed with male subjects.  Future studies are warranted to investigate 
whether female adolescent animals would have similar behavioral and 
neurophysiological outcomes following repeated exposure to AMPH.  It’s plausible that 
repeated AMPH exposure produces disparate outcomes in males and females given 
previous reports that highlight sex differences in neurodevelopment and drug-induced 
behavior across adolescence.  In regards to the mesocorticolimbic system, the degree 
of maturational changes and the timing of those changes both vary depending on sex.  
For example, the number of neurons, synapses, and dendrites changes during 
adolescence, albeit, these changes are typically more robust and occur earlier in 
females relative to males (Markham et al. 2007; Koss et al. 2014; Willing and Juraska 
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2015; Drzewiecki et al. 2016).  Thus, the timing of drug exposure during adolescence 
may lead to differential effects on females relative to males.  Recent reports from our 
lab suggest there are no appreciable differences between males and females exposed 
to AMPH during adolescence in regards to executive function and affective behavior 
(Hammerslag et al, 2014; Kang et al, 2016b).  Interestingly, exposure to AMPH before 
the onset of puberty had unique effects on dopamine D1 receptor expression later in 
adulthood in both males and females despite the fact that females reached puberty 
approximately 5-10 days earlier than males (Kang et al, 2016b).  Yet it is interesting 
that, as outlined in Chapter 2, exposure to AMPH possibly before and across puberty 
onset (see Kang et al, 2016b for mean age of pubertal onset of male SD rats) led to 
working memory dysfunction later in life.  The relationship between pubertal timing and 
the effects of AMPH on cognition and PFC maturation are only beginning to emerge and 
it would be interesting to investigate this relationship in regards to the behavioral and 
electrophysiological outcomes reported in Chapter 3. 
Sensitivity to AMPH-induced reward and locomotor sensitization appears earlier 
in females relative to males (Cirulli and Laviola 2000).  In addition, females develop 
neurobiological and behavioral sensitization more rapidly than males (Camp and 
Robinson 1988).  The precise mechanisms for these sex differences in AMPH-induced 
behavior are unclear, however, maturational differences in the mesocorticolimbic 
dopamine system between males and females have been documented previously.  For 
example, changes in dopamine D1 and D2 expression are modest in females across 
adolescence, while both receptor subtypes undergo drastic overproduction and pruning 
in males (Andersen et al. 1997).  Interestingly, manipulation of gonadal hormones at 
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puberty or earlier do not influence these sex-specific changes in dopamine receptor 
expression (Andersen et al. 2002).  Nonetheless, sex differences in the development of 
the dopamine system may contribute to differences in AMPH-induced behavior between 
males and females.  The results discussed in Chapter 3, demonstrate that in males, 
repeated exposure to AMPH leads to long-lasting locomotor sensititization to AMPH and 
dopamine-receptor selective drugs, as well as hightened sensitivity of PFC neurons to 
these drugs.  The acute effects of adolescent AMPH exposure on monoamine 
transmission varies between males and females, and repeated exposure to AMPH 
leads to long-lasting sensitization of midbrain dopamine neurons in males (Labonte et 
al. 2012; Weiss et al. 2015).  Sex differences in sensitivity to AMPH and neural 
maturation, warrant future studies to assess whether neurons in the mesocorticolimbic 
dopamine system of females are differentially sensitive to AMPH-induced plasticity 
compared to males.  A further understanding of sex differences in drug-induced 
plasticity will be paramount to developing interventions for psychopathologies that arise 
in association with drug exposure during mesocorticolimbic maturation.   
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